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Abstract
Medicalization as a Trojan Horse: Changes in Erectile Enhancement Advertising
By Robert D Wood, M.S.
A Thesis submitted in partial fulfillment of the requirements for the degree of Master of Science 
at Virginia Commonwealth University
Virginia Commonwealth University, 2011
Major Director: Sarah Jane Brubaker, PhD, Graduate Program of Sociology
This thesis investigates the medicalization of “inadequate penis size” through an analysis 
of online advertising of “male enhancement,” or erectile enhancement (EE) products. The 
process of medicalization, as defined by Peter Conrad, is the process by which non-medical 
problems become defined and treated as such (2007). With the advent and success of Viagra 
(Sildenafil) in 1998, a wave of products emerged treating erectile dysfunction and not long after 
followed the expansion of the market for erectile enhancement.
Although several studies have been done of erectile dysfunction, there has been less 
research on the advertisement techniques within the erectile enhancement market. Brubaker and 
Johnson's article “'Pack a more powerful punch' and 'lay the pipe': erectile enhancement 
discourse as a body project for masculinity” dissects such advertising for overarching themes of 
violence, the subjugation of women, and the perpetuation of hegemonic masculinity (2008). This 
analysis was done in 2006, and evidence presented in this thesis suggests that the advertising 
6
techniques, particularly as they appear in erectile enhancement websites, show some dramatic 
differences in presentation and themes. These more recent advertisements seem to reflect a more 
medical approach, emphasizing an authoritative medical appearance, downplaying violent, 
misogynistic, or sexist undertones consistent with much of erectile enhancement advertising. 
This new medical approach is a metaphorical Trojan horse, sneaking in and maintaining older 
concepts of domination and violence. The background of hegemonic masculinity in erectile 
enhancement advertising is continued under the guise of medical professionalism. Through 
quantitative and qualitative analysis of ten erectile enhancement product websites, I show how 
the advertising involved in this industry has attempted to medicalize the small penis in hopes of 
marketing an “inadequate penis” as a more legitimate, medical concern. This study thus 
contributes to a better understanding of the changing social concepts of manhood, how the 
process of medicalization works, and how it can be seen within the area of erectile enhancement. 
7
Introduction
Treatments of erectile dysfunction and the sexual focus on the penis both have long and 
complicated histories. Starting in the late 80s and early 90s a host of products became available 
for treatment of erectile dysfunction (Rowland and Burnett, 2000). What is relevant here is the 
more recent medicalized treatment of erectile dysfunction, culminating at the release of Viagra 
(Sildenafil) in 1998. Although a separate topic in its own right, Sildenafil helped to expand the 
market of erectile enhancement into both the recreational use of prescription drugs as well as the 
advent of over the counter medications (Aldridge, 1999). Additionally, many would argue it even 
altered the sexual landscape of the United States (Loe, 2006).
Violence and concepts of gender play their own roles here as well. Documented by 
Brubaker and Johnson, hegemonic masculinity and violence surround modern concepts of the 
penis, specifically when it deals with advertisement of erectile enhancing products (anything 
meant to increase size, frequency, or stamina of the erection) (2007). Other research will be 
presented which shows the progress in the medicalization of the penis itself, culminating most 
recently with the medicalization of the “limp” penis as a treatable disorder via prescription 
medication such as Sildenafil and its competitors in the treatment of erectile dysfunction (ED). 
Anecdotal evidence suggests this has gone further, with a seeming increase in advertisements and 
cultural adaptations which surround the small penis with concepts of inadequacy, avoidable 
through the use of medication or treatment. With as many as 45% of men unsatisfied with the 
size of their penis this is a large and even expandable market for the erectile enhancement 
industry to capitalize on (Lever, Frederick, and Peplau, 2006). 
Looming capitalist expansion, however, is not the only concern here. More seriously, this 
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study centers around a concept refereed to by Conrad and others as disease creation or disease 
mongering, where consistent human conditions are intentionally promoted as problematic, or 
even as a disease, in order to increase marketability. A host of ethical concerns complicate this 
process, specifically as it takes place within the authoritative setting of the medical industry. I 
will reference a number of related examples, including Andropause, baldness, and the 
importance of breast size, but particularly the case of erectile dysfunction.
The Statement of the Problem will briefly introduce erectile enhancement as a social 
phenomenon, and the importance of analyzing any possible signs of medicalization, and the 
dangers if this continues. Conrad's work on medicalization will provide the basis for the 
theoretical framework, as it will be used to assess these possible changes. Additionally, the 
Theoretical Framework will describe Conrad's framework as it applies to general social trends as 
well as specifically to perceived changes in erectile enhancement marketing. The general process 
of medicalization as well as its practical application in this thesis will be covered thoroughly, 
here. Other related works, such as on the medicalization of erectile dysfunction, the various 
treatments for it, the changes in advertising to men and men's bodies, the trend of dissatisfaction, 
and more gender related concerns will all be covered in the Literature Review. 
The methods section will primarily lay out how the websites were found, how the data 
was gathered, and the necessary justifications for these methods. Next, the sample section will, 
one by one, provide a brief but thorough qualitative look at the ten websites chosen for this 
study. Analysis and coding procedures will be covered in the following section, detailing exactly 
how the data was compiled for analysis, and the findings section will detail, primarily, the 
quantitative data gathered from the various sites. Discussion will follow, emphasizing major 
9
trends in the data as well as the important implications of such findings.
10
Statement of the Problem
Various literature already exists discussing erectile dysfunction and its treatment, 
particularly since Viagra (Sildenafil) became available to the public in 1998. Rowland and 
Burnett's 2000 article discussed early changes in the treatment of ED, while other work has more 
recently discussed longer term and broader effects of this specific treatment as well as the 
process of medicalization as it applies here (Cappelleri et al, 2007). Erectile dysfunction, 
although it was not always the case, has become defined and treated as a medical condition, fully 
satisfying Conrad's definition of medicalization (2007). Where as impotence, historically, can be 
looked at as a natural human condition and effect of aging, it is now more commonly defined and 
treated as a medical issue, specifically a biological one or biomedical. This process brings the 
'limp penis' fully into the realm of the medical authority. Erectile enhancement is another matter 
altogether. An inadequate penis, although implications may vary, has not yet been deemed a 
medical problem in the way Conrad describes. It has not reached a point where it is being 
medically diagnosed and treated. In this sense, and with the lack of direct prescription drugs 
(although prescription drugs designed for aiding erectile dysfunction are used for erectile 
enhancement), it does not fit the same definition. Quite the contrary, as Brubaker and Johnson 
(2007) illustrate, erectile enhancement advertisements have quite often exhibited a much greater 
focus on (and the exploitation of) feelings of inadequacy within the male population and the use 
of violent imagery suggesting the domination of men over women. 
Conrad's framework for the process of medicalization, however, is still applicable here. A 
non-medical issue is not simply transformed into a medical one overnight, there is, rather, an 
often lengthy process leading to varying degrees of medicalization. Although doctor prescribed 
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medications may, at times, represent a peak in medicalization, various human conditions may 
make large steps towards this point without ever being considered fully medicalized. Patients 
become consumers of an idea; drugs and the diseases they are supposed to cure are specifically 
marketed to them, and in this way non-medical issues can even become diseases themselves 
(Conrad and Leirter, 2004). Impotence and poor sexual performance, then, has come under the 
blanket term of erectile dysfunction becoming a treatable medical disorder. Many would argue 
this is quite intentional (Loe, 2006). It appears that erectile enhancement advertisements may be 
undergoing a similar change, at least in certain forms, where the violent imagery and appeals to, 
and reinforcements of, hegemonic masculinity may become less obvious, replaced by concepts 
of the 'inadequate penis' as a more legitimate medical concern. Legitimate or not, or even if this 
is merely an intentional misleading of consumers to expand a market, the use of varying medical 
language and doctor sponsorships can illuminate the process of medicalization as it applies here, 
and even justify treatment with over-the-counter or the off label use (or even abuse) of 
prescription medication. 
This is compounded with the tremendous effect media can have on body image. Hatoum 
and Belle make this very clear. Lever, Frederick, and Peplau, however, bring more disturbing 
figures to light, with results from their survey published in 2006. Specifically, while 85% of 
women reported being satisfied with their partners penis size, only 55% of men were satisfied 
with their own. The 45% of men who wanted a larger penis did not vary in age, as this figure was 
consistent from age 18 through 65. Less surprising but equally important was the correlation 
between those of above-average penis size with the most personally favorable mentions of their 
appearance. In short, those with larger penises are more confident in general (Frederick, Lever, 
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and Peplau, 2006). Penis size, then, is seriously interwoven in concepts of self. More 
dangerously, the process of medicalization as applied to erectile enhancement has further 
implications. In a country where as much as half of it's citizens are labeled ill by some form of 
medical authority, every bit of additional medical expansion poses a threat (Conrad, 2007). 
Different learning styles come to be labeled as learning disabilities or ADHD and treated with 
medication, and every new label and medical treatment further increases standards for human 
society: attentiveness in the case of ADHD, height in the case of human growth hormone, breast 
size in the case of breast implants, or sexual performance into old age with ED and Viagra 
(Conrad, 2007). This is, in many ways, a form of social control, and in the hands of medical 
professionals but particularly pharmaceutical corporations, the risks are much greater when so 
much of the motivation relates to profit, and thus the need to monitor this process is equally 
great.
A 2006 report cites that drug companies in the United States spent a whopping $4.2 
billion on direct to consumer advertising in 2005. That is a roughly 20% increase year to year in 
spending, growing much faster than even the money spent advertising to physicians (United 
States, 2006). This situation does not look to be improving either. The FDA, which monitors 
advertising of drugs to consumers, has dramatically decreased in their policing of advertising, 
sending out a mere 21 citations in 2006 compared to 142 in 1997, all while the amount of 
advertising had increased 3 fold (Donohue et al., 2007). The sheer amount of money involved 
should be telling of possible ethical considerations which I will outline in detail later, and 
reinforces the need to analyze medicalization as it presents symptoms within modern advertising.
In regards to the changing scenery of erectile enhancement advertisements, the process of 
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medicalization as outlined by Conrad in The Medicalization of Society and other publications 
shows great explicative potential. It is important to determine to what degree the 'small penis' has 
been transformed from the realm of biological trivialities and embarrassment towards that of 
more socially legitimate medical concerns. The research question for this study is, then: To what 
degree has the 'small penis' become medicalized? In order to answer this, I have looked for and 
identified the signs of medicalization as they should appear in website based erectile 
enhancement advertisements, and then what I later found in these websites. This is, then, a 
content analysis of erectile enhancement advertisements as they are found on their respective 
websites for EE products, found via common internet searches.
14
Theoretical Framework
The questions here will be answered under the guidance of a medicalization framework, 
examining the extent to which the “problem” of the 'small penis' is moving towards being 
defined and treated as a medical condition, or more specifically a biomedical condition, 
signifying the focus on biological functions in the discussion of both cause and treatment. 
Patients, in this case, are consumers, and the targets of erectile enhancement advertisements. 
Advertisements can sell drugs (and sometimes other treatments), but also can sell the 'small 
penis' itself as a disease. This concept of disease mongering will be discussed, as well as 
examples of where similar transitions have occurred  in the past.
First, the importance of medicalization as definition will be discussed, and how 
conditions come to take on definitive medical labels. The second section will  provide details for 
how and why medicalization is considered a process and not just a state of being for a condition. 
This process implies that varying degrees of medicalization are in fact possible and 
commonplace, and that despite limitations in the specific case of erectile enhancement Conrad's 
concept of medicalization is both relevant and helpful. The third section will address the medical 
market and how it expands through advertisements, the importance of looking for changes in 
advertising techniques, and how they impact society and related to the changing doctor-patient 
relationship within society. The final section will address the destigmatizing effect of 
medicalization itself. Understanding this effect is integral to understanding medicalization and 
some of the common traits shared by the various examples. 
Medicalization as Definition
There are a number of layers to the definition of medicalization. Various social factors 
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surrounding any sort of condition affect how we can attempt to view its position in the 
medicalization process. Conditions can be defined in medical terms, described using medical 
language, viewed directly within a medical framework, and can eventually come to be treated 
through medical intervention.  For instance, Merriam-Webster defines the term erectile 
dysfunction, first, specifically in their medical dictionary. The definition supplied is a “chronic 
inability to achieve or maintain an erection satisfactory for sexual intercourse.” The use of 
language like 'chronic inability' and 'satisfactory' together take this inability to maintain an 
erection and attempts to draw a line between where it is and is not a problem. If one's erection is 
not satisfactory for sexual intercourse, then by definition one has a dysfunction. Clearly we can 
define erectile dysfunction, already in both medical terms and within a medical framework, and 
other definitions present the condition in a similar manner. A (Google) web search for “what is 
erectile dysfunction” leads to a host of similar definitions, but more importantly, descriptions of 
the dysfunction framed as symptoms. These symptoms, such as they are illustrated at 
www.whatiserectiledysfunction.com allow for everything from occasional or limited-period 
dysfunction, to “permanent loss of erectile function.” Again, strong medical language is used 
here framing the condition within the medical model without direct, or at least visible, link to any 
physician or medical professional.
Most attempts to understand erectile dysfunction, then, must adopt some sort of medical 
framework for understanding. Definitions are provided by medical groups, using medical 
language, and are framed within the realm of modern medicine providing various symptoms for 
what is labeled a dysfunction. One must accept this framework before any serious understanding 
can be gained. The last major factor here, though, is the most outwardly obvious. It is the 
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'treatment' through medical intervention. We have a human condition here: the inability to 
maintain an erection. It is defined in society in medical and biological terms and described in the 
same manner within a medical framework. Even though the previously mentioned website, as 
well as many others, mentions erectile dysfunction as both a physiological as well as 
psychological problem, the standard explanation is biological and the standard treatment is 
pharmaceutical. Surgery may be an option, and psychological therapy may help, but the cost 
effective nature and reliability of drugs like Viagra seem to weigh more heavily than possible 
side effects or alternative, more 'natural' approaches. With Sildenafil's release in 1998, and the 
host of competing drugs which surfaced after (including Tadalafil (Cialis) and Vardenafil 
(Levitra)), prescription based oral medication has come to dominate the treatment of this 
dysfunction. 
These four concepts as mentioned above - the definition in medical terms, the description 
using medical language, the use of a medical framework for understanding, and the use of 
medical interventions in treatment - are all perhaps better understood not as sufficient conditions 
of medicalization but as different routes within the process of medicalization. Medicalization is a 
process and not a diagnosis, and this also means that conditions must be medicalized to different 
degrees. Conrad's framework is helpful here, where various human conditions can be analyzed 
for progress within medicalization. This sorts of measurements will be discussed further in the 
Measuring Medicalization, in the Methods section later on. 
Although Conrad (2007) points out that much work exists that is critical of over-
medicalization  (2007), it is not my intention to question the legitimacy of defining erectile 
dysfunction as a biological and medial problem. This is less a concern to me as my goal is to lay 
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the framework for how to examine the medicalization of erectile enhancement as it has changed 
over time. 
Medicalization as a Process
Conrad points out that the process of medicalization has been the topic of sociological 
analysis and discussion since the 1970s. The process, however, has changed over time, 
particularly through the 1980s and 1990s. Doctors were, and to a degree still are, the gatekeepers 
of medical treatment and thus play an important role in the process of medicalization. Their role, 
however, has become more subordinate, with direct-to-consumer advertising of prescription and 
over-the-counter drugs having an increasingly greater effect (Conrad, 2005). This changing 
relationship will be discussed later, but important now is the general loss of control doctors have 
experienced over this process. Also, the connection from this process to erectile enhancement 
may be visible with recent drug advertisements such as Enzyte and new terminology and 
common phrases such as “male enhancement” making their way into common language.
I propose that the framework of medicalization can thus be used to show both how far the 
idea of the 'small penis' or insufficient erection has moved towards becoming a medical problem, 
as well as the significance of the changes in erectile enhancement advertising and the future 
implications of this.
According to Conrad, “'Medicalization' describes a process by which non-medical 
problems become defined and treated as medical problems, usually in terms of illness and 
disorders” (2007, p. 47). Medicalization is not the state of being medicalized, or the status of a 
disorder once it attains a specific rank or is allotted prescription drug treatment. It is the 
transition from one point as a general social or human problem to another as a medical problem 
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where it is treated as such. I intend to examine the extent to which erectile enhancement for the 
“small penis” has begun this process, through visible changes in EE advertising on websites.
The Medical Market
With virtually any condition in modern day for which there is a profitable medical 
treatment there follows a medical market. The markets profit and expand through advertisements 
which target those who may not have previously sought help or medical treatment. Conrad and 
Leirter discuss a great many examples of such direct-to-consumer advertising of prescription 
drugs such as Viagra and Paxil, as well as the increased use of human growth hormone (HGH), 
and the rise of in vitro fertilization (2004).  This affects the power shift towards consumers over 
medical professionals, discussed further later. It is important to examine how these markets work 
and how they may grow and change to accompany erectile enhancement products, as well as the 
ethical implications of the process overall.
These ethical violations play directly into advertising from pharmaceutical corporations, 
and the steps taken to bring these products to market. Dishonest product research is a big part of 
the problem, and the process of advertising expands the domain of this, making room for new 
procedures and thus more consumers being put at risk. This continues, however, given that 
advertising is sufficiently incorporated into the realm of business that it is removed from the 
ethical considerations of medicine and biomedicine. Business ethics, after all, are quite different 
in regards to corporations, pharmaceutical or not. The central motivation is always the increase 
of stock value and thus shareholder wealth. Generally speaking, an 'ethical is legal' approach is 
taken, and ethical transparency virtually vanishes (Poitras and Meredith, 2009). Advertising, 
within the realm of business, thus allows pharmaceutical corporations a sort of exemption from 
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the medical ethics which might normally govern behavior. This sort of free pass prohibits some 
much needed criticism and questioning of this form of disease mongering.
The end result of the various advertisement techniques at work here, where specific 
symptoms are often listed in order to help viewers self diagnose, is that diseases are marketed 
many times just as much as their cures (Moynihan et al., 2002). In particular, Conrad's example 
of Paxil (paroxetine hydrochloride) is quite relevant. The drug was released in 1996 into an 
already saturated anti-depression medication market. The reaction of the manufacturer was to 
apply the drug, in addition, to markets for obsessive compulsive disorder (OCD), anxiety 
disorder (AD), and general anxiety disorder (GAD). Conrad cites this maneuver and the 
simultaneous marketing of the diagnoses for OCD, AD, and GAD, as factors in the 
medicalization of emotions such as worry and shyness (2007). Various other conditions are 
mentioned here, particularly andropause (male menopause) and its lack of unique symptoms, and 
the increasing use of testosterone replacement therapy in its treatment. 
Modern marketing techniques and changes in the power held by doctors has accompanied 
a shift towards self-diagnosis in society. (Conrad, 2007). Sociological and psychological 
literature abounds on how media influences people, but it is important here to see how a general 
media influence can change how medicine works in society (Kolbe et al., 1996). While more 
available medical knowledge may be a positive in society, a tendency towards self diagnosis 
supported by these advertisements may leave more room for both under and over-diagnosis of 
illness which may even be treatable without medicine. This ties back to erectile enhancement, a 
growing market centered around promoting insecurities over a traditionally non medical issue. 
This sort of marketing has had a definite effect on the Doctor-patient relationship quite 
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directly. Trends in marketing and towards self diagnosis shift power towards the patient, now in a 
consumer role. They (the patient) are the target of large scale direct-to-consumer advertising, and 
have access to a wealth of, if not always accurate, medical knowledge online. WebMD.com is 
one of many options and provides general and specific health related news, as well as a program 
they call the WebMD Symptomchecker. Users input some basic demographic information, and 
proceed to select body parts and local symptoms from an interactive human figure. Each specific 
symptom selected then corresponds to a suggested cause or condition. Selected conditions then 
link to pages detailing, amongst other things, larger causes, at home care, and details for when to 
seek a medical professional. Interestingly each WebMD.com page is accompanied by a small 
print disclaimer reading “WebMD does not provide medical advice, diagnosis, or treatment.” The 
result here is no different than how Conrad outlines it through the recent changes in society. 
Patients have taken a heavier role in diagnosing themselves and in choosing their medical 
treatment, even prescription treatment requiring a doctor (Conrad, 2005).
Medicalization can thus be viewed simultaneously as an agent of social change as well as 
one of social control (Conrad, 1992). In a related article, Bull addresses changes in society over 
time, particularly focusing on trends of secularization and medicalization. He argues that, 
although medicine may not have completely become the social guardian of morality, it is none 
the less a very powerful and influential source of and model for social change (1990). In even 
more detail, Conrad separates the changes in the medicalization process into three primary 
groups: advances in biotechnology, the influence of patients as consumers, and the influence of 
managed care (2005). All three of these have had profound effects, but most important to this 
study is the discussion on consumers and medicalization. Doctors were and still are the 
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gatekeepers for medical treatment, but their role has become subordinate. Medicalization is now 
driven more by commercial interests of larger corporations and the interests of the various 
consumer markets, rather than by the guidance and interests of medical professionals. This is, 
again, particularly visible in the case of erectile enhancement advertisements, either in the form 
of emails and online web banners as discussed by Brubaker and Johnson (2007), or through more 
recent television ads for products like Enzyte. All of this change, though, has not altered the 
definitional center of medicalization as described earlier (Conrad, 2005). 
Advertising and Medicalization
Advertisements of medical treatments have visibly increased over time.  Magazines, 
television, and websites today carry advertisements for everything from treatments for restless 
leg syndrome to sleeping pills, and include both erectile dysfunction and erectile enhancement 
medications as well. Where as other countries may have regulations against being able to 
advertise such products, the FDA in United States has overseen the expansion of direct-to-
consumer advertising of prescription drugs through loosening regulations (Donohue, 2006). This 
has had a tremendous impact. Loosened regulations allow a newly unrestrained expansion of 
medical domain, advertising diseases and their cures alike and ignoring a host of ethical concerns 
related to this process (Poitras, 2009)
It is this change in medicine that is so important, where humans have gone from being 
mere patients, ill and deserving of aid from their fellow human beings, to consumers. There is a 
great deal of money to be made from medicine. Steadily increasing over time, the percentage of 
the United States gross national product spent on health care hit 16% in 2006, and there is more 
room than ever for large corporations to make a profit and thus a much greater 'need' for 
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advertising (Conrad, 2007). The diseased and ill are a market, and in general they consume 
various medicines as those selling the medicines compete against one another for a larger share 
of profits. These markets, however, are not simply being sold medicine. They are being sold 
diseases. Markets have expanded from the ill and diseased to the healthy and normal who are 
convinced that their lives could be enhanced and improved through medical intervention. In this 
sense I examine how and the extent to which the erectile enhancement market has been expanded 
in the various website advertisements being studied
Destigmatization
Another integral trend in the process of medicalization, and one involved in almost all of 
the various paths and examples, is destigmatization. This relates to baldness, but is also visible in 
erectile dysfunction and erectile enhancement. It could be argued that men are expected to do 
something about their baldness, but the mere existence of treatments make such problems less 
stigmatizing. Conditions at one time considered embarrassing become 'medical problems' and are 
thus more easily excused by individuals in society. To a degree, baldness becomes less something 
to hide or be embarrassed of as there are treatments available (Conrad, 2007). Assuming one has 
the money for it, baldness needs no longer be hidden via the use of a toupee, as it can be 
permanently fixed with either medication or surgery. The problem here, however, is that stigma 
is removed so long as treatment is sought. Without individual acceptance of the 'problem', and 
acknowledgment of the biological factors and medical treatments, the stigma may remain, even 
stronger than ever.
Through mass-media advertisements and common discussion erectile dysfunction has 
undergone a degree of destigmatization. For those with the means, erectile dysfunction no longer 
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needs to be the source of embarrassment. It has become a legitimate medical concern in many 
respects, and it is now more likely that one could more openly admit having “performance 
issues” without fear of judgment from others (Conrad, 2007). The entire process of 
medicalization, the medical terminology in definition and description, the use of a medical 
framework for understanding, and the adoption of medical treatments, all play a role in 
destigmatizing these embarrassing human conditions.
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Literature Review
This study is centered around the small penis and how erectile enhancement 
advertisements propose solutions to this perceived problem. The literature here will cover a 
variety of topics centered around erectile enhancement and erectile dysfunction as it is related, as 
well as the dangerous implications of this process.. The first section will address medicalization 
in general as well as related concepts as they bring up possible dangerous outcomes. The process 
of medicalization has many consequences and negative social implications which will be 
discussed here. Erectile dysfunction in particular, and the history of medicalization it has 
undergone will also be discussed in another section. This is extremely important as, while 
erectile dysfunction and erectile enhancement are separate issues, many of the medications 
treating ED are used recreationally for the purposes of erectile enhancement. Additionally, many 
of the social issues of concern are consistent between the two, if not even more severe in the case 
of erectile enhancement. Viagra will additionally have its own section, as the research on the 
drug is expansive and the effects it had both on the medical market and society are equally so. 
The next section will discuss marketing techniques as they apply to men's bodies, as this is 
related direct-to-consumer advertising and the advertising of various erectile enhancement drugs, 
the following will address the general theme or presence of dissatisfaction regarding ED and 
erectile enhancement advertisements, and the final section discusses gender issues related to 
medicalization, in particular the medicalization of small breasts, the further social impacts of this 
process, and its relevance to the study of the medicalization of erectile dysfunction.
Dangers of Medicalization
Drug companies can now not only advertise their own patented drugs to doctors, in the 
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hopes of swaying their supposedly impartial opinion, but since the deregulation of advertising of 
prescription medication in 1997 they can also advertise directly to consumers. The significance 
of this is tremendous, with now almost 15 years of drugs, and their respective conditions and 
diseases, being marketed to consumers, playing up their role in the medical field in opposition to 
the role of physicians. What's more, with this form of advertising being economically successful, 
the implication is then that consumers are actually being convinced, correct or not, that they 
possess some condition in need of that specific advertised medical product. Medicalization itself 
has a great many social implications when used to analyze these related changes in society. 
Power, in the social sense, is shifted in the favor of the medical industry, now taking control of 
larger and larger portions of human existence, specifically claiming authority over more and 
more human conditions (Poitras, 2009). The implications, however, become much more serious 
when one views this process from an economic perspective.
It is this change in medicine that is so important, where humans have gone from being 
mere patients, ill and deserving of aid from their fellow human beings, to consumers. There is a 
great deal of money to be made from medicine. Steadily increasing over time, the percentage of 
the United States gross national product spent on health care hit 16% in 2006, and there is more 
room than ever for large corporations to make a profit and thus a much greater 'need' for 
advertising (Conrad, 2007). 
When tied to direct to consumer advertising, which itself has very specific monetary 
goals, medicalization takes the form of what Poitras and Meredith call economic medicalization 
(2009). The distinction here is almost entirely in motive, justified given the inherent purpose of 
direct to consumer advertising. By their definition, economic medicalization is the process 
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whereby non-medical problems are transformed into medical problems for the purpose of 
achieving corporate shareholder wealth maximization. This motive, the expansion of a medical 
market through advertising directly to consumers, solidifies the ethical concerns laid out by 
Conrad and adds even more. This trend creates ethical concerns for the basic approval process 
for medical research, and branches into multiple schools of ethics, medical ethics, bioethics, and 
business ethics. 
Where as self regulation is certainly a plausible solution to the ethical concerns which 
naturally exist in medicine, many of these regulations set forth by the AMA are already broken 
regularly, and are wholly threatened by the expansion of prescription medicine advertising. The 
focus on shareholder wealth and profits, integral to any corporation's success, necessarily 
conflicts with these principals. As an example, Poitras and Meredith document cases of 
intentional violation of informed consent, patient privacy, and the general do-no-harm condition 
for all of medicine. Specifically, it is found that within the realm of medical testing, that is 
ensuring that medications are safe for mass use, these three are often violated. Documented cases 
are presented of pharmaceutical corporations ignoring unfavorable early test results, skewing and 
violating the entire process of informed consent, as well as 'doing harm' by not providing the full 
list of possible risks to those that may be testing the product (2009). 
Reinforcing many of Conrad's statements about the willingness of the medical profession 
to accompany big business, Poitras and Meredith also cite some statistics on physicians. Of a 
2007 sample of over 1,200 physicians, 3% had been paid for recruiting people into clinical trials, 
9% had been paid for participating on advisory boards, 16% we paid for speaking engagements, 
18% were paid consultancy fees, 35% had received reimbursements for prescriptions, and as a 
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whole, 78% were financially involved, in one way or another, with the pharmaceutical industry 
(2009). Conflicts of interest abound here, when these gatekeepers of medicine profit so directly 
from the growth of an industry, on the backs of the sick and easily convinced, the very people 
they are obligated to help.
Conrad details much of these dangers thoroughly. The disease mongering carried out by 
pharmaceutical corporations operates with the direct goal of convincing people, living with often 
relatively common conditions, that they are ill and in need of often expensive medical treatment. 
How many fewer people would be diagnosed with erectile dysfunction if doctors and 
pharmaceutical companies did not make a profit from its proliferation? With the modern spread 
of anti-depressants as well, Conrad describes the medicalization of emotions like sadness, 
leading to a society, in the United States, where as much as half its citizens are medically 
diagnosed as ill in some form or another (2007). Divergences from normal behavior turn 
common human conditions into pathologies, and Conrad imagines a very realistic and in his eyes 
likely future where through genetic interventions society will produce babies free from low 
academic intelligence, shortness, poor athleticism, or a propensity towards chemical addictions. 
Whether these changes can be considered improvements is up for debate, but the motives behind 
them are far from altruistic.
New medical normalities are being imposed, intentionally, and from powerful sources, 
without regard for social repercussions, all in the name of profitability. Shortness, for one, has 
fallen into the real of medical authority with the use of human growth hormone. HGH is used not 
only on children with a deficiency in this natural product of the body, but for exceptionally short 
children as well who do not have the deficiency, functionally increasing standards for height in 
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society. Various diagnoses for social anxiety also share this pattern, where now almost any 
discomfort in public speaking can make a sufficient case for medical treatment. Lastly, the use of 
Viagra and other drugs in the treatment of erectile dysfunction has dramatically increased sex 
standards for men, and indirectly for women, by allowing and even expecting men to stay 
sexually active into their elderly years (Conrad, 2007). As with erectile enhancement, this 
process exploits men, expecting more of their body than it's nature normally allows, and 
profiting off of this artificial need. 
All of medicalization, however, shares the problem of focusing almost entirely on the 
individual level of health concerns. Conditions are marketed as very real problems, possessed by 
individuals and treated on an individual basis. Social consequences of this model of treatment, or 
the social causes themselves, are ignored as long as there is a convenient medical means for 
treatment (Loe, 2006). 
Medicalization and Erectile Dysfunction
Erectile dysfunction, as a condition, has had a long history in the medical field. Newer 
treatments like Viagra and its various competitors seem easy and effective compared to older 
treatments, and the reality is that they are. Older treatments are generally viewed, and were thus 
avoided, as being quite unnatural or perhaps too invasive. Even when viewed in a more positive 
light, many were still either ineffective or generally unsatisfying in use. These treatments ranged 
from implanted penile prostheses to externally applied devices like vacuum pumps. Modern oral 
and alternative medications are much simpler, more reliable, and elicit more naturally appearing 
and useable erections (Rowland and Burnett, 2000). This accompanied, as I discussed earlier, a 
decrease in the stigma attached to those with ED. More 'natural' treatments of ED seem, then, to 
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result in a more natural view of the medical treatment process, and this makes it generally more 
socially accepted (Alridge, et al., 1999).
The quality of life measures are linked by many sources to erectile dysfunction, 
specifically. MacDonagh et al. elaborate on the connection between erectile function and 
concepts of a healthy sex life. The overwhelming majority of survey respondents with ED 
suggested that their sexual partners regarded penetration as essential for sexual fulfillment, 
identifying a powerful motivational factor for those with erectile dysfunction to seek treatment. 
As these results would suggest, there were also high rates of insecurity among men regarding 
their masculinity, and most saw the possibilities of medical treatment as a means for reinforcing 
their manhood (MacDonagh, et al., 2004). Other studies, such as from Cappelleri et al. and 
Giuliano et al., show consistent improvements in various quality of life measurements through 
the use of Sildenafil in the treatment of ED. The SEAR, or Self Esteem and Relationship 
Questionnaire, shows marked improvement when tested on men with erectile dysfunction after 
medical treatment with the drug (Cappelleri, et al., 2007). Likewise, Giuliano, et al. shows 
similar improvements in sexual satisfaction (including overall sexual satisfaction, reported 
sexual relationship quality, and decreases in concerns about erection problems), as well as in 
measurements of mental health. Those treated saw significant improvements in reports on overall 
well being, self control, relationship satisfaction, and both relative and overall mental health 
measures (Giuliano, et al., 2001). The end result is that, regardless of the direct success of the 
drug in providing the suggested effect, erectile dysfunction treatments often attend to symptoms 
experienced by men as quite damaging to their quality of life. 
While Conrad and others discussed earlier have sufficiently made the case that erectile 
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dysfunction has been medicalized, it is important to note some of the other underlying themes 
here. As I have discussed it previously, erectile dysfunction fully satisfies Conrad's 
conceptualization of medicalization, including in its definition, sociocultural viewpoints, and its 
medical diagnosis and treatment through biomedical surgery and/or prescription medication. 
Additionally, erectile dysfunction shows many various signs of the destigmatization which often 
accompanies this process. Survey respondents were clearly not completely destigmatized, with 
many seeking treatment after solitary decision making and through secrecy and subterfuge. The 
counter, however, is that the researchers found a strong negative correlation between age and 
comfort in discussing the dysfunction. Older patients consistently expressed much more 
difficulty in, and much less frequency of, discussing their dysfunction with partners 
(MacDonagh, et al., 2004).
Overall, erectile dysfunction displays a clear transition. It's fair to say that sexual 
performance issues have remained a constant throughout human history, particularly with elderly 
men as populations began to live longer. It is the advent of Viagra, however, that helped fully 
transform this human condition into what it is today, and all of this makes a wonderful parallel to 
erectile enhancement, where medicalization in advertising can legitimate the exploitation of male 
insecurity. 
Viagra
Viagra itself was a rather important medical breakthrough. For the first time the medical 
profession had a pill to offer men unsatisfied with their body's performance. It became a cultural 
phenomenon, even, ushering in a new era of sex. Men were now allowed, and their sexual 
partners expected, to maintain an active sex life for as long as their biological functions could 
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handle it. This began a new sexual status quo, increasing expectations for performance across the 
board. The news even proudly featured older men giving up decade long marriages for new, 
young, more sexually active partners (Loe, 2006).
This was no coincidence, and as Loe points out this was the handiwork of a surprisingly 
few men. Just a handful of Pfizer (Viagra's pharmaceutical developer and owner) representatives, 
investigators, and consultants helped 'raise awareness' about a new 'problem'. This was an 
intentional and quite successful claim of new frontier, adapting and expanding the medical 
category of erectile dysfunction in order to dramatically increase product marketability. 
Spokespersons and journalists alike helped to construct a heavily sexually dysfunctional 
populace (Loe, 2006). This is yet another example of the concept of disease mongering, where a 
select few have succeeded in intentionally increasing diagnoses for monetary gain. Perhaps less 
obvious, though, is the problem that these medical solutions may not even be innately good. 
After all, how many sex lives have been damaged by suggesting that almost half of all men, at 
some point in their lives, have a problem which requires a pill to fix? As Loe points out, a hard 
penis is not always the best solution to relationship or self esteem problems.
Marketing to Men and Men's Bodies
As a general change in modern American culture, sex and sexuality has grown in both 
visibility and influence. This is compounded with the increase of marketing towards men's 
bodies, and is related in the study of erectile enhancement advertisements (Bury, 2005). Gill, 
Henwood, and Mclean's 2005 article, as well as Hatoum and Belle's 2004 article shows this well. 
Men have developed high expectations for themselves, particularly in muscle development. Sixty 
percent tend to focus on either the chest or stomach where there are often difficult standards for 
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muscle tone and definition and advertising. What's more, Hatoum and Belle found correlations 
between media exposure and self esteem, verifying their assertion that the more one is exposed 
to higher physical standards in media, the more likely one is to adopt those. This work also goes 
on to show nearly equivalent increases in standards for women, as the more men were exposed to 
media the thinner they expected women to be. This has obvious implications for the world of 
erectile enhancements and the advertising campaign that surrounds it (Hatoum and Belle, 2004). 
Greater standards for erections are promoted, which do not reflect the reality of women's 
preferences or general average size. Whenever a medical market increases, after all, society is 
collectively suggesting that a larger proportion of the population has a problem, and in these 
cases a problem in need of medical attention. 
Dissatisfaction
All of the visibility in modern media can have a definite impact on self-image and general 
dissatisfaction, after all. This will become clear with later analysis for erectile enhancement, but 
Frederick, Lever, and Peplau make the strongest case for these kind of effects in their 2006 
article. The greatest disparity was between the percentage of women satisfied with their partners 
penis (85%) and that of men satisfied with their own (55%). This leaves a substantial 45% of 
men who wish to grow their penis, which makes it obvious as to why so many companies are 
fighting for this market. Not only are men more unsatisfied than they should be, if partner 
satisfaction is the standard, but penis size is also correlated with self esteem ratings for 
completely irrelevant areas. Self reported satisfaction with men's own bodies (in swimsuits), 
faces, and general attractiveness were all positively correlated with penis size. Causation is more 
complex and difficult to determine, but the authors make an excellent case for how penis size can 
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generally increase self esteem (Lever, Frederick, and Peplau, 2006). This data corresponds well 
with additional research on body image and men. This is not a new concept, as many earlier 
publications such as Cameron's 1992 article made it very clear how culturally attached men were 
to their penises, analyzing the extensive lists of nick-names given to the male member. The 
reality is, though, that with an increase on the focus on the male body in identity, and higher 
standards for beauty, the penis is in a better place than ever to be exploited as part of male 
identity. It is no coincidence that it is often referred to as one's “manhood.” The two terms have 
come to mean the same thing in many cases. A smaller erection then equates to being a lesser 
man.
This is where we see the importance for further study. Men's bodies are being marketed 
more than ever, leaving men susceptible to attack on physical appearance. Worse yet, as society 
allows for open sexual discussion, it is met with unrealistic standards for penis size. Erectile 
enhancement products promise to provide a means to achieving happiness, found only with an 
appropriately large penis. In a sense, the erection has become a sort of postmodern body project 
(Brubaker and Johnson, 2007). Men are increasingly held to higher standards of physical 
appearance, though it is doubtful that these standards are as rigorous or time consuming as those 
of women. This has been met with a new push for hegemonic ideals and phallocentrism in 
erectile enhancement advertisements. Sex becomes increasingly important to life in general, and 
the penis becomes the central focus. This focus on the penis, however, is problematic on many 
levels, even for men themselves. Not only are standards unrealistic, but men become vulnerable 
to economic and emotional exploitation through the erectile enhancement market. This 
vulnerability, too, is here to stay for as long as masculinity is tied to this sort of physiological 
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function, and thus erectile dysfunction becomes directly related to quality of life  (Brubaker and 
Johnson, 2007).
These sorts of quality of life measures become harmful whenever they don't match up 
with reality. As detailed earlier, personal satisfaction with one's penis is far removed from partner 
satisfaction, which has negative implications for insecurity and more in personal relationships. 
These sorts of gender norms and expectations, in general, have a damaging effect on 
relationships. Sanchez makes an excellent case for this in his study of college students, where 
those most concerned with traditional gender roles and physical expectations were less likely to 
experience a quality sex life (2005). Tying in previously mentioned research we can infer that 
with larger media exposure, men develop greater standards for their own physical appearance, 
the majority of which do not match up with attainable goals for either muscular build or penis 
size, and are thus more likely to experience personal dissatisfaction with themselves and in 
relationships.
Even prior to the advent of Viagra, there is research to show the increasing importance of 
the penis, and specifically the erection, in body concepts and its medicalization. “Sexual virility- 
the ability to fulfill the conjugal duty, and the ability to procreate, sexual power, potency- is 
everywhere a requirement of the male role, and, thus, “impotence” is everywhere a matter of 
concern” (Tiefer, 1994, p. 364). This sort of phallocentrism, however, is not static in degree. 
Even simple assessments of the use of the term “impotent” in articles shows a marked increase 
since the 1970s. Phallocentrism, then, becomes normalized as erections receive greater focus. 
Mass media has found a great deal of profit focusing on sex and sexual performance, and as long 
as penis size is tied to these assessments, insecurities will fuel the marketability for erectile 
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enhancement. This post-modern masculine ideology makes men susceptible to this. The perfect 
penis becomes a requirement for perfect sex, which is maintained as a universal though 
unattainable goal. Even more, sex is increasingly expected to occur throughout life, and with 
modern medicine there becomes little excuse for a lack of “performance” even into senior years 
(Tiefer, 1994). Generally speaking, the more society finds a means of medicalizing the penis, the 
less acceptable it becomes to be unable to maintain an erection. Then, the more society creates 
standards for larger erections, the more medical terminology we wrap around it, and the more 
medicines we provide to “relieve” this problem, the more unrealistic our standards get. 
Men's personal expectations for their own penises are already unrealistic. Their personal 
satisfaction does not match that of their partners. Even those women speaking out against the 
requirement for larger erections are generally ignored (Tiefer, 1994). Men are, via media and 
advertisements, presented with unrealistic standards for erection size, and the solution to general 
troubles in relationships and with women is being sold as the possession of a more powerful 
erection (Brubaker and Johnson, 2007). Hegemonic masculinity is being recoded, here, while 
medical markets are exploiting increasing standards for erection size.
 Gender and Medicalization
Not only the topic of erectile enhancement, but the more general process of 
medicalization also relates to gender in many ways.  Andropause, as I mentioned previously, is 
one major example discussed by Conrad and others. More familiar is the process of menopause, 
a clear example of a female human condition having undergone some of the processes of 
medicalization. This maturation of the body, particularly the cessation of function with the 
ovaries, accompanies many unpleasant “side effects” some of which can be treated in various 
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manners, specifically through prescription medication. On the other hand, men's testicles do not 
just stop functioning at a certain point in body maturation. Andropause, then, has come into place 
as a term used to describe what amount to general symptoms of aging. As men's bodies age, there 
is a gradual decrease in the production of testosterone which can have a number of effects on a 
person including a general lack of energy as well as a decreased libido, erectile dysfunction, and 
more (Conrad 2007). Symptoms compatible with these accompany what is now called 
andropause, and the decline in testosterone can be difficult to measure accurately. Despite these 
difficulties and a great deal of vagueness, doctors have now started treating andropause with 
testosterone replacement therapy. It is not my place to make a call on how “real” andropause is, 
but it illustrates the process of medicalization as well as it does some of the gender dynamics at 
play. 
Childbirth, on the other hand, is a very real focal point for the process of medicalization. 
Even today there is still immense debate over the importance of and difference between natural 
and medical childbirth. Whereas birth itself is something purely natural, the way it is handled in 
modern society is not. Particularly in America, natural and medical childbirth can often be 
spoken of based solely on the presence or absence an anesthetic or analgesic (Brubaker and 
Dillaway, 2006). From a medicalization framework, though, the change has been drastic. Where 
once women were considered to have better, even ultimate knowledge of the birthing experience 
and how to handle it, today this knowledge is dominated by the medical field (Brubaker, 2009). 
Now women are encouraged, even expected to consult a physician throughout the entirety of the 
birthing process. Through the process of medicalization, an illness or deviance can gain 
legitimacy. Modern birth exemplifies this, where the birthing mother is legitimated via 
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consulting a physician.
Trends even within childbirth are not absolute, however. Periods of demedicalization 
have occurred as well, making this an even greater example of the intricacies of the process. 
Even now, the word natural in reference to birth is almost synonymous with good, and feminist 
critiques of medicalization share some overlap with this. These critiques focus on the dominance 
by medical professionals rather than by pregnant women, citing changes in authority, the setting 
of birth, and the technology being used (Brubaker, 2009). The usurpation of authority at the 
hands of medical professionals maintains a medical dominance over the field, but there is no 
shortage of recent activism for natural birth, ranging from a lack of anesthetics to modern use of 
midwifery. 
All of this is related to the social construction of the body pointed out by Lupton (2003). 
Western medicine and other influences have had a profound effect on the social construction of 
the body, how we view and interpret it, and how we modify it. Baldness, as an example of 
medicalization, is an example with much more clear opposition.
Baldness, after all, can hardly be viewed as an issue of any direct physical or mental 
danger. Although the social repercussions may spill over into other aspects of life, baldness is 
more than most a clearly, at least biologically, harmless phenomenon. We have, however, come 
to view baldness as unattractive in society, but this degree of social change is only compounded 
by the medical 'advancements' which surfaced more recently. We now have a very clear medical 
understanding of baldness, in society, particularly the genetic pattern which causes it and how 
this gene is carried from generation to generation. Once labeled as genetic there are a great deal 
of social interactive implications, particularly as the relationship between 'unattractive' and 
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'medical problem' get closer and closer. Today we have various prescription medications 
(Rogaine and Propetia) as well as hair transplant surgery available to 'cure' anyone suffering 
from this genetic condition, assuming they can pay what the market demands. The end result, 
though, is that something which has nothing to do with health and wellness, and everything to do 
with perceptions of beauty, has become medicalized. It could be argued even that modern men 
are expected to do something about their baldness, given the array of curative procedures, and 
thus this becomes a direct monetary exploitation of men over a predominantly male condition 
(Conrad, 2007). What was unattractive has, for the most part, become a social problem, 
particularly for those afflicted by it. The medical market has expanded, producing a life-long 
prescription based “cure” for baldness and stands to benefit from this for as long as it remains an 
unappealing and otherwise incurable issue. What's more, through direct to consumer advertising 
these pharmaceutical corporations continue to sell baldness as a problem, maintaining that 
society has, will, and perhaps should view it as a problem in need of a cure (Conrad, 2007).
This is far from the only case related to medicalization with more obvious economic 
interests and gender dynamics at play. One other major example is that of breast size. This is 
certainly an issue of changing cultural standards, for one, as bigger has not always meant better 
in regards to breast size, as it seems to today (Conrad, 2007). The modern idea of female beauty, 
particularly as it stands in the United States, seems to combine an unhealthy low weight with 
disproportionately large breasts. These standards increase along side, and Conrad would argue 
because of, new medical advancements in breast augmentation. In the 50's, a minority of 
physicians even went as far as to use the term 'micromastia' to describe small breasts as a 
legitimate medical concern (Berney, 2001). This is an obvious and direct attempt to bring a 
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purely aesthetic issue into the realm of medicine. It simultaneously reinforces the sexual 
objectification of women by conceding that small breasts are a problem, while masking it under a 
veil of medical authority. Medical labels like “micromastia” bring in a heavy tone of 
professionalism for describing what amounts to nothing more than beauty standards. This sort of 
masking of objectification is obvious here, but is also relevant to many gender-based medicalized 
problems, including baldness, menopause, and birth, where the male dominated medical 
authority sought to gain power in the very female centered experience (Brubaker and Dillaway, 
2009).
Thankfully, these physicians were in the minority and small breasts are not, today, 
considered a direct medical problem, but this has not stopped the advancement of augmentation 
techniques and their increasing use. Silicon implants of the 1960's began a new era of breast 
augmentation, with more women than ever seeking to, almost entirely for cosmetic reasons, 
increase their bust size. Only a minority of procedures are done for reconstructive reasons, and 
despite specific problems with older silicon implants, new technologies have allowed breast 
augmentation to become the second most popular cosmetic surgery in the United States (Conrad, 
2007). Despite remaining a decidedly cosmetic issue, and thus failing to satisfy parts of Conrad's 
definitions of medicalization, breast augmentation remains a procedure fully under the control of 
the medical industry, and very profitable as well.  In a way, this case compares more closely with 
erectile enhancement than erectile dysfunction does, as there are cases of direct exploitation of 
the respective sexes, through expanding medical markets and simultaneously increasing 
standards for body proportions. 
To emphasize the point, and stress its relevance to the topic of study here, this process of 
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medicalization directly, and perhaps necessarily, obscures the damaging nature of these sorts of 
gender politics. Medicalizing small breasts serves only to satisfy a male preference regarding the 
female body while endangering women through the use of unnecessary, and at times quite 
dangerous, procedures (Conrad, 2007). A professional, medical tone can inhibit critical analysis 
in this way, as Conrad alludes to, where these innately harmless human conditions come to be 
embraced as medical concerns and the politics behind them are thus more easily ignored. 
If erectile enhancement is being medicalized, perhaps in a similar way to small breasts, 
there are additional implications. Erectile enhancement advertisements, as Brubaker and Johnson 
discuss thoroughly, exhibit a great deal of aggressive language and generally embrace and 
promote the domination of women through the 'selling' of a larger penis (2008). This surpasses 
the objectification of women through medicalizing small breasts by medicalizing an industry 
interwoven with outright domination.  Similarly to other cases, then, this process stands to 
further mask the gender politics playing out in the erectile enhancement market, and makes this 
an important area of study. Together with baldness and andropause, then, these provide modern, 
explicit examples of the medicalization process, how it can relate to gender, and the social and 
ethical repercussions.
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Methods
In this section I provide some background information on medicalization not yet covered, 
which is central to the process of content analysis being used in this thesis. Afterward I will 
outline my specific research question as well as the units of analysis and keywords, and identify 
both population and sample groups. Coding, analysis, and limitations will be discussed as well. 
The process for developing this research format as well as the guidance for analysis will be 
provided by Klaus Kippendorff in his book Content Analysis: An Introduction to Its 
Methodology (2004) as well as other sources.
Measuring Medicalization
Medicalization is the process by which non-medical problems come to be defined and 
treated as such. There are various paths through which this can happen, including but not limited 
to the use of medical terms in both definition and description, the use of a medical framework in 
understanding, and the use of medical treatments. As a process, it is clear that medicalization can 
take place over different periods of time and to different degrees. Socio-cultural definitions of 
medicine, and what is and is not a medical issue, change over time and are deeply influential of 
and influenced by consumer markets. Regarding erectile enhancement, however, the form of 
medicalization which is relevant is actually biomedicalization. The distinction here is that 
biomedicalization, as in biomedical, refers to a process of medicalization which handles 
biological functions (Conrad, 2007). The erection is discussed as a biological function, and 
indeed common medical treatments are also discussed in regards to their manipulation of human 
biology to create the desired outcome (usually a larger, longer lasting, or more frequent erection).
In relation to erectile enhancement and advertising, medicalization stands in contrast to 
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advertising techniques promoting what are considered holistic or alternative treatments. By 
definition, alternative medicine or treatments are any which do not fall within the confines of 
conventional medicine. In the US, for example, we could generally say that conventional 
medicine includes anything regulated by FDA. Indeed, the most common and widely known 
alternative medicines and treatments are referred to as such for just this reason (e.g. chiropractic 
treatment, acupuncture). Herbal remedies often fall into this category as they are also not 
regulated under the FDA, and it is these same herbal supplements, found in many of the erectile 
enhancement products to be discussed, which leave room for alternative strategies in advertising. 
If an erectile enhancement treatment, then, is composed entirely or primarily of non-FDA-
regulated herbal supplements, manufacturers can advertise in a way which dismisses the 
conventional medical establishment and knowledge (FDA), offering instead a more 'natural' and 
'healthy' alternative to the consumer.
It is this patient, then, that is now a major player in the larger functions of medicalization 
in this consumer role. Consumers hold a lot of power, and are yet still greatly influenced (if not 
manipulated) by the pharmaceutical companies and larger medical industries via advertising and 
other methods. These markets play out within and are influenced by larger gender concepts. 
Certain conditions and aspects of health may be more medicalized for one gender than the other, 
though this changes over time (Kolbe et al., 1996). What's more, the larger process of 
medicalization tends to have a destigmatizing effect for those experiencing the designated 
problem, assuming they can afford the cure. All of this plays out on a highly social level where 
concepts and definitions are free to change, albeit slowly at times.
Many of the ways in which we can measure medicalization are rather slippery and at 
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times open to interpretation. One historical example which Conrad presents is the DSM or 
Diagnostic and Statistical Manual of Mental Disorders. Viewing the various editions of this 
manual, readers can see when various conditions are added, how they are defined and assessed, 
and how these definitions change over time. The inclusion and removal of homosexuality in this 
manual as a mental disorder is the subject of much debate and conflict, but more than anything is 
a representation of changes in the social views on it over time. More recently, the inclusion of 
attention deficit disorder (ADD), adult ADD, and attention deficit hyperactivity disorder 
(ADHD), and the adjustments made to each over time from edition to edition, are also signifiers 
of changing public and medical opinions. Conrad again points out how media influenced adults 
engage in self-diagnosis, seeking out physicians to confirm their adult ADHD (2007). 
Unsurprisingly, accompanying this increase in ADD/ADHD diagnoses comes the added burden 
of disability claims by adults, seeking special treatment and care to compensate for their 
difficulties dealing with this new disease. The trouble with the DSM, however, is that inclusion 
of a condition often represents a peak in the medicalization process, and thus is generally useful 
as a tool of insight for larger changes in the past, not for analyzing new or slow medical 
changes. 
Demedicalization, conversely, can occur when disorders are removed from the DSM 
manual, as in the case of homosexuality. These various paths to medicalization, then, are not one-
way streets. As science progresses and finds less evidence for physiological disorders, or as 
medical markets shrink, or as morality enters into play such as in the treatment of other human 
beings who could be diagnosed as having a homosexual 'disorder,' demedicalization can occur. 
Where as the medicalization of small penis has not made its way to the DSM through erectile 
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enhancement, the limp penis, and erectile dysfunction, has become thoroughly medicalized 
without need of the mental disorder centered DSM, and thus stands as a solid reference point.
Without any direct checklist for the medicalization process, Conrad's thorough 
discussions of the various aspects and paths to medicalization go a long way in aiding this thesis. 
Certain cues such as the appearance of a mental condition in the DSM may give us more obvious 
evidence that something has been further medicalized, but in general, this framework provides a 
means for the social analysis of human conditions as they change in conceptualization over time. 
Additionally, as the DSM caters specifically to mental disorders, it will be of little use here. 
Nevertheless, this type of search for evidence will be important to keep in mind as we look for 
various symptoms in the market of erectile enhancement. Within the medicalization of Erectile 
Dysfunction we saw a change in definition, the use symptoms to diagnose a problem, and direct, 
official, and prescription-based medical regulation and treatment. In erectile enhancement we 
will be looking for many similar things. Advertising web pages should provide a source of 
varying definitions for what constitutes a small penis, a problematic erection, or one generally in 
need of enhancement, as well as the possible symptoms of such a problem and the suggested 
treatment. This may come in various forms, displaying various aspects of biomedicalization, 
alternative medical trends, or more, all of which will be looked for and discussed in the 
following sections.
It is my goal, then, to use this framework of medicalization as a reference in exploring 
erectile enhancement advertising and the themes at play. Following my research question as 
outlined below, I look for and analyze these signs of medicalization as they appear in the 
websites studied.
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Research Question
Based upon the literature directing this study, the principle research question is: What 
signs of medicalization do recent erectile enhancement advertisements show? To support this 
question, I in effect measure the degree to which these forms of erectile enhancement 
advertisements have become medicalized. Brubaker and Johnson's work displays a variety of 
violent, misogynistic imagery coupled with trends towards promoting dissatisfaction and 
insecurity with 'unsatisfying' erections. Anecdotal evidence suggests that this may be changing, 
or may at least appear different in the form of singular advertisement websites, perhaps in favor 
of a model similar to that of erectile dysfunction as discussed earlier. Whereas the erectile 
enhancement ads studied still clung to themes of domination, the treatment of erectile 
dysfunction, if it was ever promoted in such a way, maintains a clean and medicalized status in 
the medical market. Then to what degree, if at all, have erectile enhancement ads, particularly 
through online websites set up for direct promotion, avoid violent and misogynistic themes in 
favor of more socially acceptable, medicalized themes? The websites selected for analysis here 
provide a snapshot of some of the current trends in erectile enhancement advertising, and thus 
also provide a means for exploring how medicalization comes to appear in these ads. As Bernard 
suggests, content analysis is to be based around hypotheses (2006). My general hypothesis for 
beginning this study was, then, that erectile enhancement advertisements, in the form of singular 
websites in the form outlined in the following section, display significant trends of 
medicalization under Conrad's framework, and are thus likely to pose similar social concerns as 
the examples listed before. As evident in the Sample, Findings, and Discussion and Conclusions 
sections, these websites did display major emphasis on a professional, medical appearance. This 
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implications of this are elaborated in detail in the Discussion and Conclusions section.
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Sample
The data for this study consist of erectile enhancement websites, specifically those 
websites meeting two prerequisites as discussed below. I also analyzed four sub-pages in 
addition to the “home” page for each site, wherever applicable. For comparison purposes, as 
individual page length can vary wildly, word counts have been recorded for each page, 
enhancing reliability (Krippendorff, 2009). Websites selected were to meet two primary 
requirements: 1- That the web page exists for the advertisement of a single specific product from 
a single specific manufacturer, and 2- That the product is promoted for the purposes of enhancing 
erectile size, stamina, frequency, or any combination thereof. These overlapping requirements 
ensure that the website directly seeks the promotion of a single erectile enhancement product 
resulting in more relevant comparison of web sites' content. Where web sites do not meet those 
requirements, they may not represent the manner in which the manufacturer wishes to sell the 
product, and this may reduce reliability in analysis. This can be difficult to determine at times, so 
only websites with clear sponsorship from a manufacturer will be chosen, i.e. they advertise that 
specific product and only that product.
Erectile enhancement products also come in a variety of forms. Based on preliminary 
searches via Google, these range from oral medication, to topical creams, to suction pumps, to 
stretching techniques. Any sale or website centered around the latter two (suction pumps and 
stretching techniques) will be excluded. These are removed primarily because the number of 
erectile enhancement pills and creams are already vast enough to be compared within that 
specific subgroup. The manufacturers of these products, also, may be quite different in structure 
from the pharmaceutical companies providing oral medication or creams. Stretching techniques 
48
are specifically problematic in comparison due to the difficulty in patenting, which reduces the 
profitability and thus the motivation to actually sell the 'product' as opposed to providing it free 
online. Additionally, when comparing pills, creams, tension rings, pumps, and stretching 
techniques, the first two are intuitively more easy to associate with the medical profession. This 
makes those products not only more relevant to this study, but a better area in which to search for 
signs of medicalization. Various tools and pumps are, simply, more difficult to present in a 
medical manner, and excluding these provides for more uniform results in analysis, where 
varying results are less likely to be explained by differences in product type and related 
advertising trends.
Erectile enhancement pills and creams, by themselves, provide a variety of alleged 
benefits as mentioned earlier. Some are advertised for the purpose of increasing erection size, 
others for increasing erectile and sexual stamina, and still others are merely advertised as Viagra 
alternatives, many useable without a prescription which and advertised to be taken recreationally 
with the goal of providing 'on-demand' or easier erections. Even more tend to provide a 
combination of effects, or at the very least suggest that they do. Given that all three of these 
'goals' overlap in terms of how they are advertised, and that single pills or creams often promise 
multiple effects at the same time, none will be excluded for the purposes of this study.
The population of study here, then, is all erectile enhancement websites promoting the 
sale of a single, physical product, an erectile enhancement pill or cream, with the web pages (and 
up to four sub pages) as units of analysis. Given Krippendorf's content analysis guide, these 
criteria should be specific enough to allow for accurate analysis (2009). The sample, then, is a 
total of ten different websites for ten different products, found by using google.com as a search 
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engine to gather simultaneously, the most relevant and popular treatments under the category of 
“erectile enhancement” products. 
A search via google.com for the string “erectile enhancement” on April 13th 2011 yielded 
“About 4,230,000 results”. Not all are useful, however, and using the requirements set forth 
previously I followed the results in order to procure a list of ten erectile enhancement products 
with unique websites that met those criteria. In order of appearance in the search results, they 
were as follows in Table 1. 
Table 1- Sample
# IN ORDER OF 
APPEARANCE
PRODUCT NAME PRODUCT WEBSITE
3 Passion Rx http://www.raysahelian.com/erection.html 
5 ViSwiss http://www.viswiss.com/ingredients.php 
6 MaxSize http://www.mdsciencelab.com/maxsize.aspx 
7 Firminite http://www.firminite.com/ 
9 VigRX Plus http://www.erection4you.com/ 
15 Endowmax http://endowmax.com/ 
16 Stallion XL http://www.hardererection.net/ 
22 RevitaleX http://www.nitrexlabs.com/ 
26 ViceRex http://www.vicerex.com/ 
29 ExtenZe http://www.buyextenze.com/index.html#back 
Products
The first site selected, for the product Passion Rx, was a one page site presented purely as 
a doctor recommendation. First, to make note of the name, Passion Rx is one of two products in 
this study using the obvious Rx (which amongst other things is most commonly used in the U.S. 
as an abbreviation for prescription, as in prescription medication). This foreshadows a trend, 
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which I will discuss later the Discussion and Conclusion section, where these non-prescription 
drugs mimic the appearance and/or atmosphere of prescription medications while still 
emphasizing their non-prescription nature. The page itself, Fig. 1 below, leads with the title 
“Erection Pill, vitamin, herb and supplement- Natural Male Erection Enhancers that work, 
alternatives to prescription medications- By Ray Sahelian, M.D. Male Problem review due to 
diabetes, impotence.” These “Natural Male Erection Enhancers” described throughout the page, 
though, are limited specifically to Passion Rx, and the benefits of this specific product are 
described throughout this near image-less, black and white page seeming to mimic a journal 
article more so than an EE advertisement. In addition to listing the benefits of Passion Rx as 
including improvement of libido, erection function, better orgasms, and increased stamina, the 
page features a great deal of bio-medical language describing the physiological functions behind 
“healthy” and “unhealthy” erections. Nearly half of this 3,227 word page is devoted to a sort of 
FAQ section covering email questions one assumes were received by Dr. Ray Sahelian, though 
this is never explicitly stated. Questions range from “Is my erection big enough?” to “Is Passion 
Rx safe if I have recently had a stroke?” Plugs for the product are found throughout these.
ViSwiss, Fig. 2 below, was the second product page within the search results, and began a 
trend of presentation vastly different from the Passion Rx page and more similar to the following 
pages. Subtitled “The Ultimate Male Enhancement Pill” this page begins with a large banner 
featuring the product logo, an image of the 30 capsule bottle, a close up of the faces of a man and 
woman smiling while facing each other in a bed, and a list of magazines the product has 
“appeared in” including Men's Health, Maxim, Men's Fitness, Natural Health, and more. 
Additionally, the center of the page features an embedded YouTube commercial video which 
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starts playing automatically. It leads with the phrase “You're not alone, millions of men suffer 
from ED” and goes on to advertise the benefits of the product in a similar manner to the rest of 
the home page. Sub-pages, in order of appearance on the left-hand bar, include Buy Now, About 
Us, How It Works, Ingredients, Success Stories, FAQ, 100% Guarantee, and Contact Us. The 
content on these sub-pages is well organized into the respective titles, and as a whole the 8,816 
words from home page through How It Works presents similar themes as will be seen in many of 
the following pages.
 The third applicable site from the results was a small, one page, 533 word listing for 
MaxSize, Fig. 3. This page is similar to Passion Rx, virtually image free featuring only an image 
of the bottle and one of a muscular man, visible from navel to eyes, posing and flexing muscles. 
Of note, the page features a banner for M.D. Science Lab, which is also the basis for the URL 
(www.mdsciencelab.com/maxsize.aspx) and as a whole, M.D. Science Lab features a host of 
products for both men and women, and for a variety of different purposes, MaxSize being their 
“Male Enhancement Formula” for the increase of erection size, “aiding” the consumer with “the 
latest advances in research and technology.” No actual doctors are mentioned or pictured on the 
MaxSize page, the M.D. Science Lab home page, or any linked pages.
Firminite's website, number 7 in the Google search results and Fig. 4 below, provides a 
presentation similar to ViSwiss. The page begins with a larger logo, subtitled with “Faster... 
Stronger... Longer...” alluding to the possible benefits of the product. Additionally, an animated 
banner alternates text and images of the product packaging, satisfied looking customers, text 
describing product benefits, and an image of a Dr. Runels who's endorsement is referenced 
throughout, as well as on his own sub-page. This was by far the largest product page, as with the 
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first four sub-pages included (How It Works, Why Firminite, Dr. Runels, and Testimonials) it 
totaled 17,604 words. Testimonials intersect almost every page, despite having their own page, 
and redundant advertisements for Firminite litter the right-hand sidebar. Some bar graphs 
illustrating the products performance are on the home page, and the How It Works sub-page 
displays a great many physiological diagrams illustrating how erections work, how blood flows, 
and how the pill enters the bodily system to aid in this process.
VigRX Plus, the fifth product (Fig. 5) and ninth on the Google search results, 
immediately presents some similar trends. Again we find a non-prescription product with Rx in 
the name, seeming to emphasize both it's background of medical authority and it's more natural, 
non prescription approach. An image of the product packaging sits and the front of the home 
page, and an image of a Dr. Steven Lamm M.D. accents the left side of the page with a seal 
stating “clinically proven, doctor recommended.” VigRX Plus is advertised on a top banner as “a 
quality product from LeadingEdge Health, and is the first to present ten alternate language 
options for international sales. In bold yellow text with the same red background the page asks 
the reader “Do you think it's enough for her? Or maybe you can give her more?” The web page 
continues with a similar theme, emphasizing that “no matter what you can always increase your 
penis size,” playing on the assumption as many of these sites do that bigger is always better. 
Some statistics are presented as well, without so much as a footnote for a reference, emphasizing 
the proportion of men of various groups facing specific or generic erection problems. Sub-pages, 
leading to a total of 2,962 words, include Doctor Recommended, Guarantee, Ingredients, and a 
first, Clinical Studies. The Clinical Studies sub-page, in fact, presents a single study from the 
“research organization: Vedic Lifesciences Pvt.” which links to their page, 
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vediclifesciences.com. It is worth noting that, unsurprisingly, Vedic Lifesciences, whose web 
page banner states “Because Winning Is Everything,” is a contract research organization and not 
an impartial medical authority.
Endowmax comes in as the 15th result via Google, and is Fig. 6 below. This time, the 
product logo is directly accompanied by a stereotypical image of a white, male doctor in white 
lab coat with stethoscope, and again an image of the product packaging greets the reader. A level 
of professionalism is clearly being pushed with images like this, and the white-male doctor 
stereotype  appears here and in every page where a doctor is shown, visible on the front pages in 
Figs. 4, 5, 6, 7, 8, and 10. This professional male authority figure, lending credibility to the 
product is in keeping with stereotypical gender ideologies, with the strong, active, intelligent 
male authority present, even along side the objectified female sexual object. Figs. 6, 7, 8, and 10 
present both on the visible front page, alone. With Endowmax, we see an image of a woman in a 
black teddy with visible panty line, who seems to gesture “hush” to the reader, holding her index 
finger up to pouted lips, perhaps suggesting “Endowmax Penis Enhancement” should remain a 
secret while it helps you “drive women wild in bed.” The advertising is very tame, however, with 
often comparatively small text and few bold headings, and through a sort of Q&A presentation 
on the home page, the product boasts an average gain of 1-3 inches for its users. A standard white 
background with small black text remains constant throughout Endowmax's home and sub-
pages, with How it Works, Order, Reviews, and FAQs adding up to a total of 3,089 words. 
Stallion XL, the 16th result via Google and Fig. 7, originally appears at a very long URL 
(http://natural   impotencepills .com/weakerectionremedy/male-enhancement-products-in-canada-  
keep-your-erection .html ). This page, however, is merely a placeholder via a blog, with an 
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outstanding number of subject tags, obviously meant to provide a sort of fake degree of 
relevance via Google, improving the products Google ranking. Clicking anywhere brings one to 
http://www.hardererection.net, the product's permanent page. The logo at the top quotes the 
product as “The ultimate performance pill for men.” A “No prescription required!” tag is also 
featured at the top, and this time the image of the product packaging accompanies that of a man 
dressed in shirt and tie kissing the neck of woman, dressed in a low cut black top, while on a 
sofa. Themes recur throughout the home and sub-pages, advertising “100% natural ingredients”, 
“No prescription required”, “Satisfaction 100% guaranteed”, and “worldwide delivery, 100% 
discreet”. At this point, there is a clear juxtaposition of two opposing themes, authoritative 
prescription medicine and prescription free, “natural” alternatives. Indeed, these two typologies 
as they will appear in analysis seem to work hand in hand in the advertisement of these products. 
Stallion XL, with the home page and FAQ, Testimonials, and Ingredients sub-pages totals 2,694 
words.
RevitaleX appears as the 22nd result in Google and in Fig 8 below. The capitalized “X” in 
the name seems to either be emphasizing the Rx or prescription background of similar products, 
or perhaps simply using the strong “X” consonant to add some masculinity and credibility to the 
name itself. It is also perhaps one of the “oldest” looking pages, featuring clip art and text effects 
reminiscent of Yahoo! GeoCities pages of the adolescent years of the internet. A poorly cropped 
image in the top left corner features a shirtless man grabbing a large breasted woman, shown in 
nothing but a bra, from behind, and yet again we see the product packaging, accompanied with 
the slogan “Hardest Hitting, Fastest Acting Formula On The Market Today!”, next to a 
suggestive image. This time, a woman seems to be surprising her husband/fiance. She wears a 
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wedding ring, though on her right hand which covers the eyes of the man, signifying in some 
western cultures that she is a widow. A diagram just below exposes a rather simplified 
physiology of the penis and male anatomy, along with more advertised effects such as “firmer 
erections, fuller erections, [and] easier to achieve erections.” With FAQ and Testimonials sub-
pages, RevitaleX totals 2,829 words.
The 26th result, and ninth product (Fig. 9) to be studied, was Vicerex at www.vicerex.com. 
The “X” end of the product name returns again, perhaps with similar meaning as mentioned 
above. “Rock Hard Erections” titles the page, with an order number and “#1 2008 USA's Best 
Rated Most Effective All Natural Male Enhancement Alternative To Prescription Drugs”, though 
no source is given for such an award. An animated banner continues with some semi-erotic 
images, mostly of scantily clad women, though one even features a man's erect penis pressed 
under his Speedo swimwear. One advertisement unique to this page and sub-pages, though, is the 
emphasis on the products ability to maintain effectiveness when mixed with alcohol. The money 
back guarantee and the lack of a needed prescription are also heavily advertised page to page. 
Vicerex, with the sub-pages Ingredients, Vicerex Guaranteed, Vicerex Sex Pill Reviews, and 
Vicerex FAQ, totals 8,588 words.
ExtenZe comes in at the 29th result via Google, Fig. 10 below, and is by far the shortest 
page, totaling only 463 words. A picture of a “couple”, man and woman, both clad in underwear, 
sits behind the slogan “With ExtenZe you can enjoy BIGGER, HARDER ERECTIONS & better 
than ever sexual pleasure!” To the right, product packaging sits behind a label boasting “Results 
100% Guaranteed.” Advertisements for “Bigger, harder, more frequent erections” repeat, and a 
doctor, again in white lab coat with stethoscope, looks towards the reader. To repeat, six of the 
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ten pages studied contained images of doctors on the front page, and every one of these doctors 
was white and male. This trustworthy image of medical authority seems to go hand in hand with 
gender stereotypes which one might expect from virtually any erectile enhancement advertising.
                                Fig. 1 – Passion Rx Fig. 2 -  ViSwiss
57
                              Fig 3. - Max Size Fig. 4 – Firminite 
                        Fig. 5 - VigRX Plus Fig. 6 - Endowmax
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                              Fig. 7 – Stallion XL Fig. 8 - Revitalex
                               Fig. 9 – Vicerex Fig. 10 - ExtenZe
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Analysis and Coding Procedures
The primary analysis here will be quantitative, based on the frequencies of keywords 
found within the text of the pages. These keywords have been chosen based on their 
representation of various themes, which I will divide into the most relevant categories identified 
from the theoretical frameworks and literature review. In order to best represent the variety of 
possible approaches in advertising, and to ease analysis, the categories are structured as: 'bio-
medicalization', 'aggression', 'inadequacy', 'alternative medicine', and 'consumer driven'. The 
keywords from these various themes are then analyzed and chosen with their latent meaning in 
mind, and are thus sufficient for both qualitative and quantitative analysis as outlined by 
Krippendorff (2009). Given that these websites are sexual in nature, keywords with clear double 
meaning or sexual innuendo were chosen wherever this alternative meaning is both clear and 
possible to articulate. Within the themes, medicalization is of primary concern. Keywords related 
to medicalization would include words like 'research', any reference to medical doctors or 
physicians, as well as references to medical trials and their results; generally speaking any 
reference to or reliance upon the medical profession and medical industry, as well as any 
description of detailed chemical functions of the product or the presentation of symptoms, and 
any general deference to the medical profession as authority on the subject matter.  A section for 
alternative medicine is included as well, for those products showing any tendency to discredit the 
medical profession, medical professionals, or popular prescription drugs, or where non-regulated 
or herbal approaches to treatment are touted, emphasizing a more 'natural' process or treatment. 
Keywords and phrases reflecting alternate and opposing themes have also been selected. 
Brubaker and Johnson illustrate well how many websites and advertisements adopt aggressive, 
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misogynistic, and even violent themes in attempting to sell a product. Opposing the 
'medicalization' theme, keywords and phrases here would include things like 'control', 'power', 
and any references to generally maintaining a commanding status within a sexual relationship. 
Often combined with this but worthy of its own focus, however, is the tendency to support 
'inadequacy' in sex. This can come in many forms, and in a sense is ever present within all 
erectile enhancement advertisements. This typology covers keywords and phrases which 
explicitly question the size of the consumers penis, their sexual stamina, their ability to satisfy 
their partner, or general adequacy in sexual relations. 
Lastly, a final general or consumer-driven theme is needed to control for these various 
other themes. Where some sites may have a great deal of 'violent' content, this may be balanced 
out by an even greater focus on user reviews, testimonials, or proclamations of better results over 
competing products. A variety of general advertising techniques will fit in here, and provide a 
better picture for the overall makeup of the advertisement space on a given website. These 
various themes and the following codes were selected to test my hypothesis. Table 2 lists the 
original list of terms to be counted before analysis began. Table 3 lists the final form, with all 
terms for which frequencies were recorded.
Table 2- Original Typologies and Keywords
BIO-MEDICALIZATION AGGRESSION INADEQUACY ALTERNATIVE MED. CONSUMER DRIVEN
doctor association, 
chemical names, medical 
terminology (genitalia, 
receptors), medical 
explanations (blood 
flow), medical/physiology 
charts, technology, 
symptoms
strong, stud, 
ravage, back in 
the saddle, 
punish, pound, 
control, power, 
general violent or 
animalistic 
euphemisms
shame, new 
confidence, 
feel like a man, 
partner 
deserves 
better, partner 
must be 
satisfied better
herbal, non-prescription, 
references to problems 
in medical industry, 
user or patient 
testimonials, reviews 
from magazines or 
websites, product 
comparisons
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Table 3- Final Typologies and Keywords
BIO-MEDICALIZATION AGGRESSION INADEQUACY ALTERNATIVE 
MED.
CONSUMER DRIVEN
doctor, condition, 
psychological, trial, research, 
dosage, potency, formula, 
property, chemical, diagnosis, 
compound, impotence, 
symptoms, engorged, dilate, 
dopamine, nitric oxide, 
corpora cavernosa, rigid, 
chambers, neural, endocrine, 
prolactin, stimulation, 
testosterone, hormone, 
vascular, blood, muscle, 
nerve, phase, levels, 
nutrients, gland, arteries
Action, strong, 
strength, rock 
hard, steel, 
prowess, virility, 
ravage, stud, 
take, back in the 
saddle, tool, 
power, control
Small, desire 
(lack of), 
shame, 
embarrassing, 
satisfy, become 
a man, soft, 
premature, too 
soon
Vitamin, herb, 
supplement, 
natural, 
alternative, sleep, 
stress, relaxation, 
diet, exercise, 
aphrodisiac, 
material, extract, 
prescription 
Guarantee, affordable, 
discreet packaging, fast 
working, perform, long 
lasting, libido, unique, 
original blend, side 
effects (few), orgasm, 
climax, energy, tested, 
works for all men, get 
laid, safe, comfortable, 
Levitra, Cialis, Viagra, 
patented, 
bigger/harder/etc, 
confidence, not alone, 
intimate.
A few terms were removed from the original list, only if they did not appear on any of the 
10 websites. I collected data from the ten Erectile Enhancement product websites already 
discussed. Each site was reviewed for relevant content and frequencies were recorded for the 
appearance of words and phrases, divided into the typologies of Bio-medicalization, Aggression, 
Inadequacy, Alternative Medicine, and Consumer Driven. Each typology started with a base of 
five preconceived words or phrases, and these were expanded on and rechecked whenever 
synonyms and additional concepts were found. The end results was a large range of terms 
(groups of either singular words, phrases, synonyms, and relative concepts) numbering 7 for 
Inadequacy, 11 for Aggression, 13 for Alternative Medicine, 24 for Consumer Driven, and 36 for 
Bio-Medicalization (91 total).
Furthermore, after frequencies were totaled for the 10 different base sites, they were also 
totaled for the first 4 relevant sub pages for every applicable site. These sub pages were often 
labeled for specific information, and thus displayed various trends regarding recorded data. 
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These pages varied greatly in size, however, and thus a word count was taken for each page and 
sub-page in order to compute a sort of typological “density” (the sum of all frequencies of terms 
within a typology divided by the word count for its respective page). This same process was also 
used for totaling frequencies across all sub-pages. Thus, home pages like ViSwiss.com could be 
compared against the PassionRX product page, 4751 and 3227 words respectively, or ViSwiss 
and all 4 sub pages (total 8816 words) could be tallied and compared via densities. It is quite 
possible that while some individuals visiting these sites may only visit the front page, and thus 
sites can still be compared in this way, tallying frequencies and comparing via density provides 
for a more comprehensive picture of the information presented at the website.
Once the terms are totaled and factored into the word count, the result is a decimal 
representing a percentage. For reference, none in the Bio-Medicalization category became larger 
than 3.5% and as such they will be discussed as decimals. PassionRX, for example, a single page 
with no sub pages (3227 words), ended up with the highest density of Bio-Medical terms at .
03223. The VigRX Plus site (5 pages, 2962 words) and MaxSize (1 page, 533 words) came in at 
second and third places with .02566 and .02439 respectively. The lowest were Revitalex (3 
pages, 2829 words) and Vicerex (5 pages, 8588 words) at .00636 and .00536 respectively, with 
Bio-Medical terms nearing only half a percent as word content. This and the rest of the data will 
be discussed in detail in the following section
63
Findings
This section is laid out by typology as I will cover each in order and elaborate on various 
trends and themes that appear, as well as provide examples from the text. Much of the discussion 
will involve the use of densities again, and Table 4 just above the Bio-Medicalization section 
presents the total densities for each typology ordered by site. Word count is also listed for 
reference.
Gender Politics in EE Advertising
Throughout this analysis and in the Discussion and Conclusions section to follow, it is 
important to keep in mind that this process of medicalization, which I have emphasized so 
heavily, is being applied to something that is fundamentally not a medical issue, but a gender 
issue. In this sense, these various advertising techniques, outlined by my findings and the various 
densities listed already, may seek to legitimize this concern over the limp or insufficient penis 
through a decidedly medical atmosphere. In the same trend, this normalizes and legitimates the 
gender inequalities which underpin the discussion of the limp penis. Many of the examples given 
already are relevant here, where masculinity is measured via the strength of an erection, and 
women are presented simply as objects, to be obtained or to be satisfied in order to keep. Thus, 
the legitimization of the erectile enhancement market through these various means is quite 
dangerous, for it can also have serious impacts on gender politics as a whole. These gender 
politics within the world of erectile enhancement must be questioned and not allowed to continue 
under the guise of a medical professionalism. 
Tiefer speaks to this issue at length, discussing the problems of phallocentrism, 
something nearly inseparable from any discussion on erectile enhancement. Erections become 
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the essence of male sexual function, and the medicalization of this, by urologists and medical 
industries, has consequences for both men and women (1994). Human sexuality as a whole is 
damaged, where men spend time and effort in pursuit of an unobtainable perfect erection, and 
any non-phallocentric desires of women are ignored.
 Table 4 – Product Densities by Typology
Passion 
Rx
ViSwiss Max 
Size
Firmi
nite
VigRX 
Plus
Endow
max
Stallion 
XL
Revita
leX
Vicere
x
Exten
Ze
Bio-Medical 
-ization
.03223 .01301 .02439 .01301 .02566 .01554 .01782 .00636 .00536 .01296
Aggression .00217 .00397 .00188 .00489 .00540 .00680 .00668 .00212 .00338 .00648
Inadequacy .00031 .00216 .00563 .00318 .00236 .00421 .00260 .00035 .00093 .00000
Alternative 
Medicine
.03409 .01044 .01876 .01375 .01283 .01198 .02042 .01060 .00838 .01296
Consumer 
Driven
.01394 .01735 .02627 .02374 .03174 .03140 .03415 .01025 .01921 .04536
WORD 
COUNT
3227 8816 533 17604 2962 3089 2694 2829 8588 463
                                                              
Bio-Medicalization
Medicalization, as I have described extensively, encompasses the movement of non-
medical conditions into the realm of medical authority. This happens in a number of ways, as 
Conrad describes (2007). It can be a result of medical colonization, a sort of moral 
entrepreneurship, social movements, and more. Here, however, the category of bio-
medicalization seeks to illustrate examples where pharmaceutical corporations and/or small 
manufacturer groups seek to legitimize a product through medical references and medical 
authority. The small, limp, or “unimpressive” penis have not been medicalized, and thus the 
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products discussed here are not being prescribed by doctors. What we have, though, is a number 
of groups presenting an image of medical authority to make respective products seem more safe, 
reliable, or generally trustworthy. This is evident with the recurring imagery of doctors appearing 
on web pages, the outright sponsorship and the advertising of authoritative medical testing done 
on the products, as well as other present themes.
Additionally, examining the names of products as listed in Table 1 or Table 4 above, 
another trend becomes visible. Two products directly include “Rx” (U.S. shorthand for 
prescription) in the product name itself. These are Passion Rx and VigRX Plus, but RevitaleX 
and Vicerex also end with a similar strong “ex” in their product names, in the case of RevitaleX 
the final “x” even being capitalized in the logo. Obviously in the case of Passion Rx and VigRX 
Plus, and arguably in the case of RevitaleX and Vicerex, this nod to prescriptions is consistent 
with trends, across all of the products, appealing to medical authority. Including the “Rx” in the 
product name would, seemingly, convey a degree of medical authority one would expect from 
prescription medications provided by a medical professional. This is in direct contrast to 
alternative themes emphasizing the non-prescription nature of the product, which will be 
addressed in this and later sections.
This typology of Bio-medicalization is the most prevalent of the five in this study, 
representing the largest number of relevant terms recorded. A number of these terms (such as 
neural, Nitric Oxide, or condition) are used repeatedly on one or perhaps two sites, a arguably to 
present a medically professional attitude, while not being used at all on other sites, in favor of 
differing language. Many of the sites, overall, spent time (word space) discussing the 
physiological process behind erections, why the customer's might be unsatisfactory, and how 
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their product would improve the customer's erection. The variety and frequency of terms used for 
this warranted a sub category under Bio-Medicalization, distinguishing these physiological 
explanations from the more general medical terminology being used.
The Passion Rx page, for instance, talks about a number of specific chemical interactions 
in detail. In one part of a sort of FAQ section, the author talks about Nitric Oxide, “... a chemical 
in the bloodstream that helps dilate blood vessels, including those in the penis, thus maintaining 
and improving blood flow.“ This provides a solid example of the overall tone of this particular 
page. Other pages, however, leave this sort of detailing to an Ingredients page. Indeed, ViSwiss, 
VigRX Plus, Endowmax, Stallion XL, Vicerex, and Extenze all have ingredients pages which, 
with the exception of Extenze, go into specific detail on each of the main ingredients included in 
their product. These descriptions range in content as well. ViSwiss, for instance, discusses many 
ingredients by giving a cultural background. In their description of Ashwagandha root: “Some 
refer to Ashwagandha as Indian ginseng, as it is used in ayurvedic medicine similar to how 
ginseng is used in traditional Chinese medicine.“ This kind of content often emphasizes the 
alternative nature of the practice, avoiding references to medical professionals. Other sites, 
however, embrace this and thus gain higher counts in the Bio-Medicalization category through 
these descriptions. The Endowmax website, for instance, speaks of one of their ingredients, 
Epimedium Grandiflorum (Horny Goat Weed) in this way: “As revealed in a 1984 University of 
Peking study, the active chemical in Epimedium (icariin) helps nitric oxide effectiveness in the 
body as a PDE-5 inhibitor (which is the same way many prescription erectile enhancement 
products work).“
One of the most telling terms recorded here for this typology was the number of times 
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doctors were mentioned, either by description, listing of qualifications, or as a general title (as in 
“ask your doctor”). When recorded, this can be viewed as a means of deferring to medical 
authority, either by presenting a product as approved by medical professionals, or feigning this 
sort of appearance. Only the Endowmax website avoided mentioning doctors all together, with 
most websites (in total) using these terms 1 to 10 times. Firminite, however, presents a major 
outlier, with the website and sub pages using the word doctor or referring to doctors a total of 73 
times. While these individual numbers are impressive, as are the totals for other terms in this 
typology including impotence being used 39 times, and testosterone 18 times, when totaled the 
terms in Bio-Medicalization became much less impressive given Firminite's massive word count. 
The word count for Firminite was 17,604 across all sub pages, far greater than even the second 
largest set of pages, ViSwiss, totaling at 8,816. Other frequent and notable terms in this category 
included formula and impotence, and as physiological explanations discussing blood and 
testosterone were also very common. 
Aggression
Aggression is a particular typology of interest as it is most relevant to the work done by 
Brubaker and Johnson, described earlier. This section includes terms like ravage, or referring to 
men as studs. This is also where the use of words like power, control, and  tool will be recorded. 
As seen in table 3, previously, the list of terms for this category is short, particularly in 
comparison to the Bio-Medicalization and Consumer Driven typologies. Even some of the 
original entries from Table 2 were removed, as they appeared in none of the 10 websites, and few 
were added in their place. What's more, those that were most popular were generally non-violent, 
perhaps only conveying more of a traditional masculinity than the violence outlined by Brubaker 
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and Johnson. This is where the most drastic change can be seen from Brubaker and Johnson's 
work. Where aggressive language and themes of domination were quite clear and overt in their 
study, these erectile enhancement sites found via google, on a few short years later, seem to 
suppress such language in favor of medical and natural themes. The frequencies and densities for 
this typology are comparatively minute, but it is my assertion that although these themes may be 
less obvious and more difficult to quantify, they are merely obscured by the medical and/or 
natural language. I will elaborate more on this in the Discussion and Conclusions section.
A few sites were nearly devoid of aggressive language, such as Revitalex and Max Size, 
though even Passion Rx, presented almost entirely as if it were a doctor's professional write-up, 
still managed to contain a number of keywords and phrases from this category. In particular, 
erections were described as “strong” when referring to the efficacy of the product. Firminite, on 
the opposite end, repeated slogans such as “Pants-Splitting, Steel-Hard Erections in just 24 
Minutes!” often describing the process of taking the product as well as the effects as “Fast” and 
“Powerful”
These less prevalent but telling keywords and phrases speak to larger stereotypes and the 
subjugation of women. This begins, obviously enough, with the common use of the word 
“strong” to describe not just the man who takes the product but specifically his erect penis. 
However one defines the word, whether speaking of physical power or more simply health, the 
suggestion is that the best penis is a strong erect one. Violent imagery is, respectively, harder to 
come by in these pages, but the underlying themes are quite similar. Erections are equated to 
“steel” and “rock”, and even the use of the word “power”, or “powerful” in the description of 
erections, is repeated. The is unsurprising given the basic nature of erectile enhancement 
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advertising, as well as work like Brubaker and Johnson's 2008 article describing such trends, but 
these nods to the stereotypes of gender politics are no less important and dangerous here now. 
Men, throughout these pages, are consistently framed with these sort of qualifiers, women being 
merely the recipients of a multitude of varying erections, always expected to prefer those of 
larger size and “stronger” fortitude that last for the longest period of time. The powerful, 
masculine attributes are valued universally in these pages with women consistently, and only, 
providing a back drop of necessary approval, or need even, for bigger, stronger, and longer 
lasting erections.
As frequencies go, most common in these websites was the use of the word strong to 
describe either the erection attainable with the advertised product, or a general description of 
men after using it (indirectly referring to sexual prowess). Power was used a great deal, 
sometimes mentioning power men needed to obtain in relationships, in bed, or sometimes 
describing attainable erections as powerful. Rock was also a common qualifier when talking 
about erections, as in “rock hard”, with only the Endowmax and Revitalex pages avoiding the 
term altogether. 
In total, the sites here range on Aggression density from .00212 (Revitalex, 3 pages, 2829 
words) to .00188 (Max Size, 1 page, 533 words) at the bottom, and from .00680 (Endowmax, 5 
pages, 3089 words) to .00668 (StallionXL, 4 pages, 2694 words) on the high end. Although 
coming in on the lower end, ViSwiss (5 pages, 8816 words) is notable as it is the only page using 
a number of the recorded terms, including using the word ravage, describing sex as the act of 
taking a woman, and referring to a new found virility as “getting back in the saddle”. It was also 
one of only two websites (the other being Firminite) referring to men as studs. 
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Inadequacy
Inadequacy, as a category, is an opposing force to aggression in advertising, though both 
can work together as well. Where as the Aggression typology is meant to capture terms 
visualizing dominance, generally over women, Inadequacy is meant to group terms that do the 
opposite. This can range from either describing the consumer's penis as small to perhaps 
embellishing the average or needed size for a man's penis. Advertising in general plays on an act 
of expressing what a consumer is missing, and how their product can fill that void. In the world 
of erectile enhancement advertising, the idea of inadequacy directly plays on gender expectations 
and roles.
The typology includes references to helping men become desired. Indeed, while women 
play a secondary, subordinate, and receptive role here, this goal of desire seems smaller but 
consistent throughout these websites. This is problematic in that becoming desired, here, is also 
about attaining a normalcy, related to erection size and “strength”, promoted by these various 
companies. The penis that is not erect often, and strong when it is erect, is a problematic penis. 
These problematic penises are, thus, undesirable and in need of treatment. After all, women, as 
found in these advertisements, must be satisfied, and only a large and strong erection can 
accomplish this. The “normal” erection thus becomes the erection capable of satisfying a woman, 
based on these preconceptions of needed size, etc, and is the only erection capable of making 
men desired.
In general, the use of the term desired in advertising focuses on how the consumer may 
not be desired sexually or as a whole. The implication, then, is that their product, the erectile 
enhancement pill in this case, helps to alleviate the problem of not being desired. A larger penis, 
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or more frequent erections, a more “normal” one, are implied solutions to relationship difficulties 
or the lack of sexual activity, both indicators of normal heterosexual masculinity. The consumer 
cannot succeed, then, without a larger penis. A similar point is made with discussions about 
becoming a man. By using the product to attain a larger penis, or at least an erect one, the 
consumer then and only then satisfies a prerequisite for manhood. This advertising technique 
simultaneously defines manhood while insisting the consumer has failed this test, implying that 
to be a man is to have a larger penis than the consumer currently has. Ideas of inadequacy in 
advertising are thus quite unique in the advertising of “male enhancement” products as they must 
define even masculinity itself as something only attainable through their product.
The Max Size home-page even acknowledges this theme, with the first paragraph starting 
off with: “For many men, sexual performance and size, are delicate, perhaps even embarrassing 
issues.” One might expect such a revelation to be the beginning of an article critical of such an 
industry, not a page advertising a product which takes advantage of such issues. The problem, 
however, is that even a seemingly critical statement such as this still accepts the unimpressive 
erection to be abnormal, and something to be embarrassed of. The Max Size solution, then, even 
stating that “... many men do place a related value of penis size to their manhood, sense of worth 
and sexual prowess”, is to embrace “...constructive herbal aids like Max Size male enhancement 
formula.” Other websites are less direct, Firminite being a good example, where one of the 
repeated benefits of product is that “You can feel like more of a man again!” This simple 
statement, as I mentioned before, takes as granted the association between penis function and 
manhood, suggesting the appropriate action is to improve the penis rather than redefine 
masculinity.
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Desire was one of the more frequent terms found on the various websites, present in all 
but two sites, and becoming a man and satisfying her were also quite common, comparatively 
speaking. Numerically speaking, though, this typology is the least impressive. On the high end, 
MaxSize (1 page, 533 words) received a density score of .00563 and Endowmax came in close 
with .00421 (5 pages, 3089 words). On the low end, Revitalex and PassionRX scored very low, .
00035 and .00031 respectively. Extenze was most interesting, given that it is probably the most 
common name of all the products mentioned, but managed to record zero terms from this 
category. This could be explained by the small site size (only 463 words) but this is unlikely, 
given that other smaller pages like MaxSize recorded scores within a normal range in most of the 
typologies.
Alternative Medicine
In many ways, Alternative Medicine is this study's counter to the Bio-Medicalization 
category. Conceptually these terms focus on those things outside the realm of medical authority 
and control. Herbal remedies, vitamins, supplements, extracts, and aphrodisiacs would all fall in 
this category. All of the products studied here, in fact, are non prescription medications often 
emphasizing their herbal nature and qualities. As such, the most common terms used here are 
non-prescription, herbal, and natural. This category and the terms used here are often, within the 
websites, associated with a reliable and safe means of alternative treatment. In the same way that 
certain sites may emphasize the medical background of those having helped develop a product, 
others may instead choose to disregard medical authority, and claim authority instead from the 
herbal and non-prescription nature of their product.
In study, however, this section becomes slightly more different as many of the sites pair 
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notions of alternative medicine alongside appeals to medical authority. Indeed, many of these 
sites will focus on the non-prescription nature of their product, some even referencing cultural 
histories of medicinal herbs, but much of this is also approached within a medical context. 
Endowmax was already listed as an example in the Bio-Medicalization typology for its 
ingredients page, but some of the listings here more openly attempt to embrace the natural or 
alternative nature. Under Catuaba Bark, the Endowmax website states “The bark of this Brazilian 
tree has long been safely and effectively used to help diminish the effects of sexual dysfunction.” 
and the rest of the paragraph goes on to describe tribal use of the product and “believed” effects 
in remedying erectile dysfunction. These unproven “natural” ingredients are thus presented as if 
in a medical analysis of their efficacy. Lupton discusses this trend, where even attempts to avoid 
medical authority still end up working within a medical framework (2003). 
As a direct example, Lupton discusses the natural childbirth movement, which celebrates 
the “... collective, supportive female experience of birth” and yet ends up having the effect of “... 
furthering medical dominance over childbirth, by directing intense medical attention on the 
process” (p. 162, 2003). Here, attempts to naturalize this experience were self-destructive in a 
sense, but other attempts to embrace alternative, natural approaches often mimic their medical 
counterparts. This occurs through similar judgments on what is good or bad for the body (natural 
is good as opposed to medical is good, and different though similarly rigid definitions of what is 
healthy). “As a result, it may be contended that alternative therapies retain most aspects of 
medical ideology: notions of health and illness still have a medicalized and functional meaning” 
(Lupton, 2003).
As far as the quantitative scores for this typology go, the lowest here was from Vicerex at 
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less than one percent (.00838, 8588 words, 5 pages). All of the others had densities higher than 
one percent, with Stallion XL receiving over a 2 percent (.02042) and Passion Rx over a 3 
(.03409). Although some of the terms had more subtle relevance to alternative medicine, such as 
the discussion of diet, sleep, exercise, and stress behavior on some sites, the biggest buzz words, 
receiving most of the highest frequencies across all sites studied, were herbal, natural, and non-
prescription. 
Consumerism
The Consumer Driven category in this study is meant, in part, as a control. This describes 
general advertising terms and buzzwords that either do not support one of the other typologies, or 
are general enough to apply to multiple groups, and in general match the techniques used to sell 
virtually all erectile enhancement products. This would include how often (term frequency) a 
money back guarantee is discussed, or how affordable the product is in comparison, or how 
favorable it is in comparison to other big name EE brands like Cialis, Levitra, and Viagra. It also 
includes references to how well the product contributes to erectile enhancement, with a host of 
words grouped for describing how much better a persons penis will get upon taking the product 
(bigger, harder, longer, thicker, firmer, larger, etc.) as well any benefits for improving libido, 
sexual stamina, improving of orgasm, and more. FAQ sections also fit here, where space is often 
spent attempting to more directly inform the consumer on why the product is good and how 
easily they can obtain it.
ViSwiss' home page shows off images made to look like awards, ribbons, or badges, with 
statements such as “100% satisfaction guaranteed” and “100% money back guarantee.” 
Endowmax does the same with a logo emphasizing “discreet shipping”, similar to the Stallion 
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XL home page, showing off “Worldwide Delivery, 100% discreet.”
Densities in this category ranged from .01025 in RevitaleX up to .04536 with Extenze. 
What's more, for all but Passion Rx and RevitaleX, this was the highest scoring (highest density) 
typology for every EE product studied. The significance of this is mixed, however.  A high score 
in this category often simply meant more “dense” pages, filled with buzzwords and general 
advertising techniques, and seemed to have no direct impact on scores of the individual products 
in other typologies. Again, this was more of a catch-all for techniques which might not fit in 
other categories, and is not mutually exclusive in this way from the other categories.
Gender Politics
While not a typology itself, and something discussed throughout here already, the gender 
politics within these erectile enhancement websites need more specific discussion. Firstly, 
Tiefer's 1994 discussion of the medicalization of erectile dysfunction goes a long way in helping 
describe the notions of masculine identity found within these sites. Phallocentrism is easily the 
most appropriate term in describing the content found here. As discussed earlier, manhood, or the 
degree to which a male can be considered a “man”, is determined by, more than anything, penis 
size and function. This may seem inconsequential or expected given the topic of erectile 
enhancement, but it is important to remember that these websites are embracing a heavily male-
centered view of reality, and one which seeks to make men unsatisfied with their bodies, and 
place undeserved focus on erections and penetration. Visually, as seen on many of the home 
pages pictured in Figs. 1-10, images of the penis are generally avoided except in cases of more 
medical diagrams, lending more focus to functionality of the penis. Additionally, male bodies 
pictured, with the exception of the Stallion XL page and one on RevitaleX, are always either a 
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doctor or shirtless and heavily muscular, lending more focus to theme of strength mentioned 
earlier. 
Women, pictured in almost every site, are found in primarily one of two ways: Either 
modeling in some form or another, as on the Vicerex or Endowmax home pages (Figs. 6 and 9), 
or with a man expressing some form of physical intimacy (Figs. 2, 7, 8, and 10).  Additionally, 
throughout every page studied, women are never presented as medical authority figures or 
doctors, nor are they ever given an opinion outside of valuing larger erections or more 
“satisfying” and active sex life. What's more, these opinions are often second hand through men's 
testimonials, and her satisfaction, as I have already noted, is devoid of discussion on anything 
outside of penetrative intercourse. Despite in many ways being the focus of erectile enhancement 
advertising, in the sense that bigger erections are promoted for the purpose of satisfying (or 
dominating) women, they are lent virtually no voice and remain secondary, passive subjects 
serving only to lend credence to the advertisers claims on sex and sexuality.
It should also be noted that nowhere, on the ten web pages and their various sub-pages, 
was there ever mention of male on male sex. Wherever the sexual partner is discussed, meaning 
the partner of the person purchasing the product, it is without variance female. Even on the 
Vicerex page, which greets the viewer with an overtly sexual close-up of a large erection 
contained within Speedo swim shorts (Fig, 9), there is never a questioning of the dominance and 
authority of men in sexual relations by suggesting men may also be receiving these erections 
themselves. 
These specific trends are the major reasons why medicalization matters in this field of 
advertising and treatment. The process of medicalization lends credence to such products, 
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products based around the very non-medical issue of the small or “unimpressive” penis. 
Discussion and advertising of erectile enhancement products are rife with stereotypical and 
hetero-normative ideas of sexuality and virtually never deviate from this. Thus, legitimizing a 
product which seeks to label the small penis as a medical issue has profound consequences on 
social views of sex and sexuality. Men are thus not allowed to remain satisfied with a smaller 
than average erection, or even average perhaps, and any non phallocentric views of sex, from 
men or women, are discarded. It is taken as fact that women want and/or need larger erections 
despite evidence to the contrary, and all of these themes serve to damage any non-phallocentric, 
non-penetrative, non-hetero-normative forms of sex.
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Discussion and Conclusions
Throughout the previous sections I outlined the major, significant trends found in 
studying these ten erectile enhancement websites. Numerically, the Aggression and Inadequacy 
typologies scored the lowest across every website without fail. Even adding the densities of these 
two categories together for each website still creates a typology scoring lower than all others, 
again. This, coupled with a more generally qualitative look at the websites, the imagery used, 
seems to suggest a much more professional, or simply medical attitude and appearance in 
advertising. This, however, is not the full picture, and as with any EE advertising there is going 
to be a backbone of sexuality present, and this still seems filled with stereotypical gender 
ideology.
My original hypothesis was that, when compared to the cross-sectional view of erectile 
enhancement advertising given by Brubaker and Johnson in 2008, that these erectile 
enhancement websites just a few years later would show significant trends of medicalization. 
Despite the entirely non-medical nature of the small penis as a concept, and the unlikely result of 
it ever reaching full medicalization in the vein of erectile dysfunction, there was sufficient 
evidence that this is the case. Medicalization as a process, discussed in the Theoretical 
Framework section, is clearly active in these websites at the hand of the pharmaceutical 
companies and their respective advertisers. 
A Non-Violent Presentation
Contrary to Brubaker and Johnson's assessment of similar advertising, there was a general 
lack of aggressive language here. References to improving the strength of erection were 
common, as was the use of the phrase “rock hard” when describing the effects of the various 
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products. The word power was used fairly often as well, but in general this language was not the 
central means for advertising the product. These pages were, in contrast to what Brubaker and 
Johnson saw, fairly tame, even professional, in language. Nowhere was a phrase like “powerful 
punch” or “laying pipe” used, and even the more general expression of “taking a woman” 
implying sex, was used solely on the ViSwiss page. The term “stud” only came up on two pages, 
ViSwiss and Firminite, and no website used the term “tool” in place of penis. Numerically and 
comprehensively, Aggression seemed a very small focus of these advertising web pages.
The Inadequacy typology was equally weak in comparison to the other categories, and as 
said before, even when combined with the Aggression typology, the two still produced an 
insignificant category. Half of the web pages advertised their respective products as providing an 
increase in penis or erection size. Those were Max Size, VigRX Plus, Endowmax, RevitaleX, 
and ExtenZe. However, of these, only Max Size seemed to overtly address, and attempt to 
capitalize on, such feelings of inadequacy, and how men “...place a related value of penis size to 
their manhood, sense of worth, and sexual prowess.” This was still not enough for the Max Size 
page to gain a significant density in Inadequacy, though it was the highest across the ten pages. 
Like the rest of the products, the Max Size page still devotes most of it's time (words per page) to 
traditional advertising techniques (Consumer Driven) and presents these in a medically 
professional tone (Bio-Medicalization), often with a dual focus on the non-prescription and thus 
non-medical (Alternative Medicine) nature of the product.
Aggression and Inadequacy are almost unavoidable when discussing erectile 
enhancement, but the picture gained from viewing the sites qualitatively, as in Figs. 1-10, or 
quantitatively as through the densities found in Table 4, shows that these other major focuses, 
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Bio-medicalization and Alternative Medicine, have obscured and played down the exploitation of 
gender as would otherwise be found through these categories. 
It must be emphasized, though, that this does not eliminate themes of domination and 
gender inequality, it merely obscures and legitimates them. While not explicit themes in their 
own right, Aggression and Inadequacy are still present, as all of these erectile enhancement 
advertising techniques are based around the assumption that men, by nature, are inadequate and 
in need of improvement. This plays an important role in the importance of this study and the 
medicalization of erectile enhancement which I will cover last.
A Medical Atmosphere
Outside of the Consumer Driven control category, which carried an average density 
across all web pages of .02534 or 2.534%, Bio-Medicalization was the highest scoring category 
with an average density of .01672. This is where the majority of advertising focus seemed to be. 
Not only do the numbers back this up, but the imagery on many sites matched this as well. 5 
pages (Endowmax, Firminite, Passion Rx, RevitaleX, and Stallion XL) even featured images of 
doctors (in all cases white men in lab coats) immediately visible on the front page. Even Max 
Size, the highest scoring product for Inadequacy, heads the page with a banner for M.D. Science 
Lab, which as it turns out is merely the name of the pharmaceutical company making said 
product. Without clicking on the embedded hyperlink and seeing what the company actually is, 
the Caduceus (two snakes wrapped around a winged staff) seems to lend a false credence to the 
company. A medical diagram of the functions behind a penile erection, though basic, can even be 
seen on the RevitaleX home page, Fig. 8.
Quantitatively and Qualitatively these pages exhibit signs on medicalization, as laid out 
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by Conrad in his various works (2001, 2005, 2007). While not meeting the requirement 
discussed in the Medicalization as Definition section, the evidence here fully agrees with 
Medicalization as a Process, an active one at the hands of these pharmaceutical corporations who 
have much to gain by professionalizing and legitimizing this non-medical issue of the small 
penis. 
Medical authority is seen as a route to this legitimation of a product, and the perfect 
Trojan horse to maintain older, perhaps outdated, and more offensive notions of the domination 
of women and hegemonic masculinity. Clean medical professionalism is outwardly expressed, 
with more violent imagery and language obscured. Medical professionalism helps make 
professionalize the market for erectile enhancement while these older more violent undertones 
maintain a social need for the larger erection. The male doctors in lab coats are perfect examples 
here, where they tend to lend imagery of authority, but still male authority, and language 
referencing women, as mentioned in the findings section, is almost entirely objectifying, with 
women only discussed as sexual recipients, and any non-phallocentric desires they may have 
usually downplayed or ignored. In this way, the erectile enhancement market, visible from these 
web pages, seems to be making an attempt to medicalize itself, regardless of the non-medical 
nature of the products and their uses. This tends to mimic some of the post-deregulation 
advertising of prescription medications as discussed in the Advertising and Medicalization 
section (Poitras, 2009), as well as the trends in the medicalization of erectile dysfunction, and 
Viagra in particular, as in their respective sections in the Literature Review.
An Alternative Solution
One of the more surprising trends in this study was the integration of Alternative 
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Medicine in advertising approaches. The densities for this typology were on average third in or 
higher in significance, always beating out Aggression and Inadequacy, even combined, and at 
times beating out Bio-Medicalization and even Consumer Driven, as was the case with Passion 
Rx. Interestingly enough, this was the product page with the most simple but perhaps 
professional approach in appearance, entirely presented as a single doctor recommendation. 
What I found, then, was that this focus on natural elements of the product, and the non-
prescription nature of all ten of them, went hand in hand with the medical framework of 
advertising. 
Without fail, every web site for every product used the word natural in description, and 
all emphasized their herbal ingredients as well. The fact that no prescription was needed was also 
directly advertised on 9 of the 10 sites (all but Max Size). The extracts and herbs themselves 
were also discussed in detail on many of the Ingredients pages. This trend, of alternative, 
“natural” medicine, unaffiliated with medical authority, taking on a medical appearance is 
documented by Conrad (2005). These products still adopt a decidedly medical framework in 
advertising their product, but do so while simultaneously emphasizing the non-medical nature of 
the treatment, meaning that no doctor or medical authority is required in the purchase or use of it. 
These similarities between emphases on “natural” and “medical” approaches are striking. 
As discussed by Lupton, these medical and natural approaches overlap in many ways. In 
particular, she compares the expansion of nursing with that of alternative or “natural” therapies: 
“Just as the ideology of nursing, in its interest in the 'whole' person, may be viewed as extending 
the medical gaze into the personal lives of patients, so too a similar focus on all aspects of a 
patients life as championed by alternative therapists may be interpreted as an extension of 
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power” (2003). With nursing, and the general veil of authoritative medicine and medical 
professionals, analysis often points towards the expansion of medical authority, control, and a 
more invasive set of treatments. Alternative therapists, then, are often labeled as the antithesis of 
medical authority, less tested perhaps but more benevolent, looking out of the individual. Lupton 
points out that this is often not the case, and that holistic approaches in alternative medicine are 
often another form of the expansion of control and power. Thus, in the case of these erectile 
enhancement advertisements, the Alternative Medicine and Bio-medicalization typologies are in 
a way expectedly intertwined. If the goal of the advertising and pharmaceutical companies is to 
expand control, increasing sales by creating a need and an atmosphere of authority, both Bio-
Medicalization and Alternative Medicine can aid in this simultaneously. Medicalization presents 
one form of authority, and “natural” approaches in advertising another, but both seek the same 
end goal in much the same manner.
Appealing to Everyone
Just as the language of Alternative Medicine combines with Bio-Medicalization, and both 
of these obscure the gender politics of advertising a product for erections, so to does the 
Consumer Driven language integrate with all of these. Guarantee's are posted everywhere, and 
the entirety of advertising language comes in to support these present themes without 
diminishing them. Advertising as a whole, after all, must appeal to as many viewers as possible. 
Although the major themes are clear, all of the pages included some language from every 
typology with only one exception (Extenze scored a .00000 in Inadequacy, Table 4). In this 
manner, viewers who are not drawn to the dominant medical or alternative language may instead 
be pulled in by the undertones of Aggression and Inadequacy, suggesting they aren't man enough 
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without a larger erection, or that their partner will never be satisfied if they don't buy it, or that 
the product will make them irresistible in bed, allowing them to take whatever woman they 
might want. All of this, wrapped in a blanket of security, with traditional advertising language 
ensuring the product will work 100%, or their money back.
Dangers in Gender
The Marketing to Men and Men's Bodies, Dissatisfaction, and Gender and Medicalization 
sections preface much of this discussion. The subject of erectile enhancement is entirely 
enveloped in stereotypical gender norms. With women as the passive recipients of, and perhaps 
motivators for, product use, these advertisers target men and various common insecurities. This 
is in many ways a form of disease mongering, a concept covered in the Dangers of 
Medicalization section and discussed thoroughly by Conrad (2007). These pharmaceutical 
companies have a great deal of money to gain by enforcing a new medical normality, a larger 
erect penis. Again, this is obscured by the immense focus on medical professionalism, allowed 
salience in society under the guise of medical authority.
This implies then that any success in medicalizing erectile enhancement, which as I 
already discussed has been accomplished in multiple ways, can have disastrous effects on men's 
emotional well being and on the nature of sexual intimacy as a whole. Where men are already 
disproportionately dissatisfied with their penis as compared to their partners (Frederick, Lever, 
and Paplau, 2006) further medicalization serves only to increase this disparity. EE Advertising 
insists that women require larger and more frequent erections, inflating men's sexual 
expectations for themselves. This is inherently psychologically damaging given that these new 
requirements by definition exceed natural averages for penis size and stamina. What's more this 
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is sure to cause additional damage where these men, with higher expectations of themselves and 
a vision of sexuality purely penetration and phallocentric, inevitably find themselves with 
partners whose views do not match up with the focus on large erections and penetration found in 
these advertisements. In this way, Medicalization utilizes women in a subordinate role to validate 
increased expectations, fully undermining anything that could be considered healthy sexual 
interaction. This legitimates and normalizes traditional gender politics where men are the more 
intelligent and powerful actors subordinating women as passive objects, and non-hetero-
normative or non-penetrative sex are left out all together. 
One last implication comes about from these findings, though. Conrad stresses the 
destigmatizing effect of medicalization, and I have elaborated on this idea sufficiently in the 
Theoretical Framework section. Above, I have stressed the social implications of this trend, 
where men become unsatisfied with their own natural bodies as well as any non-phallocentric 
sexual relations in general. It would appear then that with the medicalization of erectile 
enhancement, a sexual and non medical issue, stigmatization may be increasing as opposed to 
Conrad's stressed decrease in stigma through medicalization. 
With the advent of appropriate treatments like Viagra, the stigma of erectile dysfunction 
is lessened. With baldness, having prescription medication to address it has also lessened stigma, 
and with the classification of alcoholism being drunk has also seen decreased stigma. In the cases 
of ED and baldness, it can be argued that stigma is decreased only with being able to afford 
treatment or giving appropriate credence to the medical authority on the issue. Stigma, none the 
less, is decreased through the medical atmosphere surrounding these issues. In the case of 
erectile enhancement, however, the medical aura of advertising serves to hide the lingering 
86
themes of violence and, in particular, inadequacy. Thus, erectile enhancement thrives with 
increased standards for erection size and thus increased stigmatization. 
This seems in many ways to be unique to this medicalization of the small penis, and is 
perhaps strongly related to its status as a non-medical and sexual issue. This analysis of erectile 
enhancement advertising thus gives us a view of the stigmatization of normal human bodies. If 
this is in fact true, then the application of medicalization in non-medical fields, erectile 
enhancement in particular, calls for greatly increased study. A stigmatizing effect of 
medicalization is not something addressed by Conrad or Lupton or, indeed, much of the 
medicalization literature. Thus, this study as well as any further research into this specific trend 
may have insights to offer into the theory of medicalization itself. 
Conclusion
These websites, referring to both the qualitative and quantitative data, have made obvious 
attempts and even inroads in medicalizing themselves. This is evident in the high densities across 
the Bio-Medicalization typology, as well as the imagery presented on many of the web sites. 
Medical language is used, doctors are named and shown in pictures, 5 of the ten pages 
specifically referred to medical research on their product or its ingredients, language like 
potency, diagnosis, and symptom are used, and in many cases web sites discussed the physiology 
behind the erection and how their product works to improve functionality. The attempt at 
medicalization is clear given the data, and the effects of this are ominous at best, obscuring 
themes much more dangerous to gender politics.
The dominance of medical language and imagery is clear in many of these pages, but this 
is not a medical issue. Smaller than average erections are not, in any real sense, a medical 
87
problem. Everything on these pages has to do with human sexuality, and assumptions about what 
this requires of individuals. As Tiefer emphasizes so strongly, this medicalization of non-
medical, sexual issues has dangerous consequences for human sexuality. Unrealistic expectations 
of performance, and in this case penis size, are promoted through advertising and readily 
accepted by society (1994). The lingering sexist stereotypes in society allow for a willing public, 
accepting of medical authority intruding on these non-medical issues. If anything, this new 
medical approach may be even more dangerous than the outward violent and misogynistic 
themes found by Brubaker and Johnson (2008). Presented in this manner, medicalizing erections, 
or the small penis, serves to aid a product, entirely based around the false sexual need for a larger 
erection, in permeating society and perpetuating these false needs, further damaging human 
sexual relations and maintaining misogynistic themes without cultivating near as much criticism.
This analysis of the erectile enhancement arena serves to illustrate a number of points: 1- 
The small penis is a sexual and social, not a medical, concern. 2- Medicalization of the small 
penis serves to legitimate lingering and harmful gender stereotypes, functioning as a “Trojan 
horse” 3- This legitimation undermines human sexual relations of all types. 4- Medicalization of 
erectile enhancement must continue to be looked at from a thoroughly critical perspective in 
order to minimize points 2 and 3. 5- Medicalization of the small penis may conflict with the 
current understanding of medicalization, actually increasing stigma. 
This study combined with Brubaker and Johnson's article serve as a clear picture of the 
violent underpinnings of erectile enhancement and the dangerous attempts to medicalize this 
field. More large scale research and longitudinal studies are needed, however, in order to better 
articulate the specific trends in medicalization here and prevent harsh social impact.
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Future Research
Firstly, this thesis focuses on merely one aspect of gender politics, the impact on sexual 
intercourse and relationships as informed and influenced by the medicalization of erectile 
enhancement. The maintenance of misogyny through this medical professionalism is highly 
important, but medicalization may impact gender politics in numerous other ways. The 
medicalization of erectile dysfunction, erectile enhancement, andropause, male pattern baldness, 
child birth, and more have a great deal of influence here and more study is needed on how this 
process of medicalization may be directly affecting gender relations.
Specifically for the study of erectile enhancement, there are also other methods which 
may improve results and later analysis. Results here show a very intentional veil of medical 
authority obscuring older trends of hegemonic masculinity and domination. More involved 
qualitative research may dramatically improve the visibility of these more obscure undertones 
where quantitative data and frequency analysis may fall short. Additionally, these websites found 
via Google searching for erectile enhancement products may not be representative of erectile 
enhancement as a whole, as searches for “penis enlargement” may pull drastically different 
forms of advertising, as would those websites found via ads from internet pornography. Future 
research with greater funding and time should seek to pull from these sources and more to 
deliver a more representative sample of erectile enhancement.
Erectile enhancement is also a larger issue than can be simplified through quantitative or 
qualitative content analysis. Network analysis, for instance, could be used to explore possible 
links between manufacturers of similar products. It's highly plausible that single manufacturers 
may be making functionally identical products with different names and advertised in different 
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ways, or even single products with multiple means and styles of advertising. This, with a 
stronger background in gender theory and more longitudinal data, may provide an even stronger 
argument for medicalization as a Trojan horse in the market of erectile enhancement.
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